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ABSTRACT 
The sites of biosynthesis and incorporation of the abundant 
CNS myel in proteins 2' , 3' --cycli c nucleot ide--i--phospho.di<1!$tero.s-(' 
(CNPase) and P2 protein into the growing myelin membrane were 
investigated. 
Cell-free translation systems programmed with mRNA from rat 
brain, rabbit spinal cord, free and bound polysomes and purified 
myelin demonstrated conclusively that both CNPase and P2 are 
synthesized on free polysomes like the myelin basic proteins (MBPs) 
but unlike the proteolipid protein (PLP), the major intrinsic 
membrane protein of CNS myelin, which is known to be synthesized at 
the oligodendrocyte endoplasmic reticulum on bound polysomes (Colman 
et al . , 1982) . 
These observations were supported by labelling studies on 
rats in vivo during the period of maximal myelin deposition. Newly 
synthesized CNPase associated with the myelin membrane very rapidly 
after labelling (-2 minutes) and this is consistent with the view 
that there is only a brief delay between synthesis and incorporation 
into their target membrane for extrinsic-type plasma membrane 
proteins. An RNA fraction isolated from purified CNS myelin was not 
enriched in mRNAs coding for CNPase and P2 but a considerable 
enrichment of mRNAs coding for KBPs was observed. This phenomenon 
has important implications for the cell biology of myelination since 
it suggests that although KBPs, CNPase and P2 are all basic 
extrinsic membrane proteins, and synthesized on free polysomes, 
different mechanisms for their transport to the myelin membrane 
exist. 
The/ 
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The addition of dog pancreatic microsomes (DPK) during 
translation showed no membrane association for CNPase however. at 
least 50~ of MBPs were observed to non-specifically associate with 
these membranes. When newly synthesized KBP and P2 were incubated 
post-translationally with DPM or rabbit spinal cord myelin P2 only 
associated with myelin whereas KBP showed an equal affinity for both 
types of membranes. The segregation of KBP free polysomes at the 
myelin membrane during synthesis ensures that the nascent KBP 
polypeptides associate with the correct membrane. 
Recent evidence has shown that the free polysome-mRNA complex 
is bound to the cytoskeleton during protein sy"thesis. After 
extensive characterization of the purified rat brain oligodendrocyte 
and myelin-associated cytoskeletons it was shown that the synthesis 
of KBPs and CNPase only occurs from mRNA that is associated with the 
cytoskeleton and not when it is part of the cytoplasmic mRNA pool. 
Lipid analysis of the purified rat brain myelin-associated 
cytoskeleton revealed the presence of tightly bound lipid with a 
considerable enrichment of cerebroside and sphingomyelin (the latter 
at the expense of phosphatidylethanolamine). 
These studies on the cytoskeletal involvement in 
myelinogenesis suggest that extrinsic CNS myelin proteins are 
synthesized on the cytoskeleton and that post-translational 
cytoskeletal transport of these proteins to the growing myelin 
membrane may take place. 
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Introduction 
1.1 HISTORICAL ASPECTS OF KYELIN 
The function of myelin is to insulate nerve fibres and thereby 
allow a considerable increase in the rate of nerve impulse 
conduction by comparison with unmyelinated fibres of similar 
diameter. 
The presence of sheaths surrounding nerve axons was first 
reported by Virchow (1854) in the mid-19th century in the first 
study to establish myelin as a structural entity. Due to the lack 
of suitable techniques at that time it was some years before 
histologists, using newly developed stains and polarization 
microscopy, could visualize the structural relationships between the 
axon and its myelin sheath. Using these techniques it was 
established that the myelin sheath was not continuous over the 
entire axon but was segmented (Ranvier, 1871). Ranvier was later to 
investigate the involvement of the segmented junctions (Nodes of 
Ranvier) in saltatory conduction, the specialized form of impulse 
conduction found in myelinated axons. 
The early work of Schmitt and his colleagues (Schmitt et al., 
1935; Schmitt and Bear, 1939) established that myelin was a 
concentric, layered structure and that it consisted of a repeating 
unit. It was possible for Schmitt to write in 1939 that, "The 
proteins occur as thin sheets wrapped concentrically about the axons 
with two bimolecular layers of lipoids interspersed between adjacent 
protein layers". 
The advent of the electron microscope and its application to 
neurobiology led to a burst of activity during which the major 
morphological features of myelin were elucidated. 
Sjostrand/ 
Sjostrand (1'949) and Fernandez-Koran (1950) confirmed that the 
structure was multi-lamellar in nature and Geren and Schmitt (1954) 
showed that myelin formation was due to a spiralling of the membrane 
around the nerve axon to form the tightly packed myelin sheath. It 
must be said that most of the early work on the structural 
elucidation of myelin was carried out on the peripheral nervous 
system (PNS) and this was due to the accessibility of the tissue and 
the ease of fixation. Studies on the central nervous system (CNS) 
comprising the brain and spinal cord lagged behind the PNS and most 
of the structural foundation work was initiated in the early 
1960's. Katurana (1960) and Peters (1960) confirmed that the CNS 
possessed a spiral configuration analogous to that of the PNS. CNS 
myelinogenesis, however, was the subject of much debate at that 
time, even the suggestion that the myelin sheath was a product of 
the axon itself (Hild, 1957). The origin of CNS myelin was finally 
resolved by Bunge et al. (1962) who showed that the cell responsible 
for myelination was the oligodendrocyte and that processes sent out 
by this cell contacted nerve axons and wrapped round them. Further 
work since that time has supported and refined Bunge's initial 
observations (Peters, 1964,; Okada, 1982). 
1.2 STRUCTURE OF CNS KYELIN 
i. Morphology 
CNS myelin is a highly specialized biological membrane that 
has evolved to provide an environment of high resistance and low 
capacitance allowing a nerve impulse to be propagated along the axon 
with greater velocity and much less energy expenditure in doing so 
than/ 
than in unmyelinated axons (Waxman and Ritchie, 1985). What are the 
special features of this biological membrane that make it so unique 
and allow it to perform this function? Under the electron 
microscope the various stages of myelination can be observed 
(Figure 1) and certain features are immediately evident. In the 
early stages of CNS myelination (Figure la) a loose wrapping of an 
oligodendrocyte process around the nerve axon is seen. ftyelination 
in the CNS is initiated when the axons to be myelinated reach a 
diameter of approximately lum, usually a few days after myelination 
has commenced in the PNS (Raine, 1984a). The oligodendrocyte 
process forms a loose cup around a segment of the axon and a further 
extension of the process results in one lip of the cup, the future 
"inner tongue" of the mature sheath, working it's way beneath the 
other. The multilamellar structure is formed by the rotation of 
this inner tongue around the axon. While the first few spiral turns 
are forming (Figure lb) cytoplasm between layers and on the outer 
and inner surfaces disappears rapidly and the process of compaction 
has begun. Compaction of the membrane layers occurs very soon after 
the initial spiralling (Raine et al., 1968) and the oligodendrocyte 
cytoplasm is reduced to a thin, continuous strip (Schmidt-Lanterman 
Incisures) located at the outer, inner and paranodal edges of the 
mature sheath (Hirano and Dembitzer. 1967). This process continues 
until the layers have fused together (Figure le) forming a single 
major dense line between the inner surfaces of the unit membrane and 
an intraperiod line resulting from the close apposition of the outer 
leaflets of the membrane. 
The ability of oligodendrocytes to synthesize myelin membrane 
is/ 
Fig . la. EM photograph [ ram a 4 day old 
kitten spinal co1.d. An 
ol1godendrocyte process c• > is 
seen loosely wrapped round an 
Fig. J ". r. later ·;tage 11 _NS myel ina tion 
than chat in Fig. la . showing 
partial compaction of the sheath 
around it's axon (A). The outer 
15 
axon (A). 
( *) 
The future inner 
1s also seen. Scale loop 
bar: o.2sr m x 48,000. 
C• ) and inner ( * ) loops are also 
observed . Scale bar: O.s1m x 27,000 
Q .., 
.,, 
. ./ 
1-1.g. le. Transvc1se section of a mature CNS myelin 
shea h [ram canine spinal cord showing the 
oule1 tongue ( - ) c1nd spiral nature o( the 
slicntll. Scale bar: O. l r m x 150,000. 
From Raine (1984a) 
is prodigious; one oligodendrocyte can myelinate up to fifty axons, 
even those that are in nerve tracts distant from its cell body; it 
has been estimated that oligodendrocytes can produce three times 
their own weight in myelin every day (Crang and Rumsby, 1978; Norton 
and Poduslo, 1973b). 
The presence of transverse bands between the lateral loop and 
the axolemma was reported by Hirano and Dembitzer (1982). These 
junctional complexes (zonulae occludentes) have also been observed 
by freeze-fracture techniques (Schnapp and Kugnaini, 1975) and are 
thought to be of functional significance since they develop after 
the sheath matures. The Node of Ranvier also contains desmosomes 
between adjacent lateral loops (Ketuzals, 1965) however the 
functional significance of this is not ltnown. 
The classic work of Bunge et al.(1961) on the structural 
analysis of myelination showed that the oligodendrocyte process that 
myelinates an axon is shovel-shaped (Figure 2) and our understanding 
of the morphology of myelination has changed little since then. 
ii. Molecular Organization 
Kyelination in the CNS is a complex process and must involve 
the involvement of many biochemical processes proceeding in a 
concerted manner. The functions of myelin lipids and proteins in 
myelinogenesis are unltnown. However, we can speculate about certain 
steps which must be key stages in myelinogenesis. 
1. The oligodendrocyte must reach a stage at which it is able to 
synthesize the specific components of the myelin sheath. 
2. The axon must reach a stage at which it can be recognized as a 
myelinat ,able structure. 
3./ 
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Fig. 2. 
Oligodendrocyte soma attached to numerous myelin 
sheaths unfolded to varying degrees. From Bunge et al. (1961). 
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3. The myelinating cell must recognize the axon to be myelinated 
as a specific target. 
4. The wrapping of the myelinating cell processes must proceed in 
such a way as to build the characteristic morphology of the myelin 
sheath, with the apposition of the outer leaflets giving rise to the 
intraperiod line and inner leaflets the major dense line. 
Kyelin is exceptional amongst biological membranes in that it 
has a very high ratio of lipid to protein (Boggs and Koscarello, 
1978a) and this fact alone would tend to suggest that myelin has its 
own rules for structural organization and assembly. Depletion of 
proteins has provided the myelin membrane with a composition which 
provides a high resistance to ion movement across the membrane and 
structural studies on the organization of the myelin membrane have 
been gained using concepts applied to other biological membranes, 
specifically protein-lipid, protein-protein interactions, membrane 
labelling with specific hydrophobic or hydrophilic probes and 
inununocytochemistry. 
(a) Location of Protein 
The first probe used to study the spatial orientation of CNS 
myelin proteins about the myelin membrane was lacto-peroxidase 
iodination (Poduslo and Braun, 1975) which showed that only PLP and 
some high molecular weight proteins were radio-iodinated. The 
results were regarded with caution however, since only the outer 
lamellae were seen to be labelled. A more permeable probe, 
salicylaldehyde, was used by Golds and Braun (1976) but resulted in 
all myelin proteins being labelled in both intact and fragmented 
myelin. A more definitive answer was obtained by using the 
hydrophobic/ 
hydrophobic probe 4, 4'-diisothiocyano -2, 2'- ditritiostilbene 
(Wood et al., 1977). Using CNS myelin fragments they showed that, 
on the basis of reactivity to the probe, KBP was much less 
accessible implying that it may reside in the major period zone 
rather than the intraperiod zone. Recent studies by Stevens et al. 
(1986) using adamantane diazirine (hydrophobic) and iodosulphanilic 
acid (hydrophilic) probes have indicated that PLP is an integral 
membrane protein whereas ftBP is found at a site inaccessible to the 
hydrophobic probe ie. the cytoplasmic face of the membrane. 
Innunocytochemistry at the Eft level has mapped ftBP to the 
cytoplasmic faces of compact myelin and has confirmed the earlier 
observations using probes (Omlin et al., 1982). 
In contrast to the two major CNS myelin proteins, PLP and MBP, 
less is known about the spatial disposition of MAG and CNPase in the 
membrane. Evidence to date has suggested that MAG is localized to 
the periaxonal region of the sheath and not in compact myelin. This 
has been linked to the idea that this protein is involved in the 
apposition of the myelin sheath to the axon (Quarles, 1984; Martini 
and Schachner, 1986). RAG has an extensive extracellular exposure 
(Poduslo et al., 1976) and proteolysis experiments have shown that a 
substantial part of the protein is firmly embedded in the lipid 
matrix (Sato et al., 1982). 
CNPase has been mapped, by inununocytochemical techniques, to 
the major dense line of compact myelin analogous to the distribution 
or ftBP (Roussel et al., 1978). Although this study observed that 
staining was evident only on the outer lamellae of the myelin sheath 
it was proposed that this was probably due to the inability of the 
antibodies/ 
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antibodies to penetrate the dense wrappings of the sheath, a result 
that was confirmed by Nishizawa et al. (1981). Supporting evidence 
for the localization of CNPase in myelin sheaths has come from 
Sprinkle et al. (1983) and Nishizawa et al. (1985) who have clearly 
shown i11111unocytochemical staining of CNPase in myelin, 
oligodendrocytes and oligodendrocyte processes. No staining was 
observed in astrocytes or neurons. 
(b) Biophysical Studies 
Biophysical studies carried out to shed light on protein-lipid 
interactions have by and large been mainly of the reassociative 
type. That is, the reconstitution of purified proteins into or onto 
purified lipid vesicles, the so called model membrane systems. By 
the use of these techniques, particularly electron spin resonance 
(ESR), nuclear magnetic resonance (NKR) and liquid diffraction X-ray 
analysis the possible orientation of proteins with respect to the 
lipid bilayer and the changes in secondary structure of these 
proteins on binding can be detected. 
Boggs et al. (1977) provided the earliest evidence that PLP 
preferentially associates with negatively charged lipids and that 
"BP also has a high affinity for this class of lipids. Since it has 
been shown that "BP is synthesized on free polysomes, is a 
peripheral type protein (Colman et al., 1982) and does not penetrate 
the lipid bilayer the question of the importance of electrostatic 
interactions in their relationship to the myelin membrane requires 
attention (Boggs et al .• 1981). However the importance of the 
involvement of electrostatic forces in the structural association of 
"BP with the myelin membrane has been questioned by Braun (1984) 
since/ 
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since the anionic lipid asymmetry of the myelin bilayer is unknown. 
He further argues that since only about 10 mole~ of myelin lipids 
are anionic other myelin proteins (PLP is cationic at physiological 
pH for example) and cytoskeletal elements would also have access to 
some of these negatively charged residues. 
Spin-label ESR (Brophy et al., 1984) and deuterium and 
phosphorus NIIR (Sixl et al., 1984; Meier et al., 1987) studies on 
reconstituted PLP in model membranes have suggested that the protein 
has a hexameric arrangement in the membrane, a fact that was 
initially observed by Smith et al. (1983) using conditions that 
produced fewer structural perturbations to the protein than had 
previously been used. PLP with its potential surface membrane 
domains may have a role to play in anchoring the apposing lamellae 
of the compact myelin sheath (Laursen et al., 1984; Stoffel et al., 
1984). 
The ability of MBP to self-associate has also been observed by 
a number of workers (Chapman and Moore, 1976; Smith, 1982). The 
protein has a strong tendency to dimerize in low concentrations of 
sos (Smith and McDonald, 1979) and the presence of covalently 
cross-linked dimers, but not higher oligomers, has been demonstrated 
in the intact myelin sheath (Golds and Braun, 1978a). An important 
discovery was made in 1977 when it was established that KBP could 
induce cross-linking of lipid bilayers in vitro (Smith, 1977) and a 
hypothesis that MBP played an important role in the interfacing of 
the cytoplasmic bilayer surfaces of CNS myelin was put forward by 
Braun (1977). Despite all the information gathered from studies 
such as X-ray diffraction, i11111unocytochemical localization of 
specific/ 
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specific myelin proteins. freeze-fracture electron microscopy and 
molecular interactions in well-defined model membrane systems (ESR 
and NMR) we have only a tentative concept of molecular organization 
within the myelin membrane. Several models have been published 
{Rumsby and Crang. 1977; Boggs et al.. 1982) andi11the latest model 
{Braun. 1984) {Figure 3) the PLP is depicted as an integral membrane 
protein in both monomeric and oligomeric forms. Heterodimers of MBP 
and PLP {Golds and Braun. 1978b) are shown as is the peripheral 
nature of KBP. Also shown is KBP with one or more domains in very 
limited contact with the hydrophobic interior of the bilayer (Boggs 
and Koscarello. 1978b) together with the presence of KBP dimers. 
Braun stresses that although structural information obtained to date 
has been on PLP and MBP{s) and that together they comprise at least 
60,. of the total CNS myelin protein this does not mean that they are 
solely responsible for holding the membrane together. However from 
the work of Kirschner et al. (1979) and Hollingshead et al. (1981) 
he proposes that once the ordering of the lamellae has been 
initiated the major proteins play a role in the maintenance or 
stabilization of the interlamellar spacing. 
iii. Origins of CNS Kyelin - The Oligodendrocyte 
{a) Differentiation In Vivo 
It is generally accepted that the first description of the 
oligodendrocyte was given by Robertson (1899) when. experimenting 
with metal impregnation of CNS tissue. he noticed small branching 
cells of "very characteristic aspect" found throughout the white 
matter of the brain. The cell's name and detailed description was 
to appear several decades later in extensive work by the Spanish 
histologist/ 
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Fig. 3. Diagrammatic representation of the molecular 
organization in CNS myelin illustrating several 
possible arrangements of PLP and MBP. (Ext.) 
Extracellular apposition (intraperiod line); 
(Cyt.) cytoplasmic apposition (major dense 
line). After Braun (1984). 
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histologist (del Rio Hortega, 1919) who demonstrated that Ramon y 
Cajal's (1913) so called third element (ie. third brain cell type in 
addition to astrocytes and neurons) was composed of two types of 
cells: oligodendrocytes ("cells with few branches") derived from 
neuroectodermal cells, and microglial cells, originating from 
mesodermal cells. The general features of oligodendroglial ontogeny 
emerged from these early studies and a number of important questions 
still await answer. Present studies of oligodendroglial genesis in 
vivo are based on morphological studies using electron microscopy 
combined with labelling studies of cells with c3H] thymidine and 
subsequent autoradiography (reviewed by Polak et al., 1982). 
The major development of oligodendroglia occurs during 
postnatal life and is related to myelination in the various parts of 
the CNS. A layer of immature cells (the subventricular layer) 
persists into the postnatal period and it is from this layer that 
cells migrate to various parts of the brain. Differentiation into 
oligodendrocytes then commences (Sturrock, 1982; Paterson, 1983) 
with the sequence as follows: subventricular cells, glioblasts, 
oligodendroblasts, light oligodendrocytes, medium oligodendrocytes 
and finally, dark oligodendrocytes (Figure 4). Postmitotic 
maturation gives rise to three morphologically distinct 
oligodendrocytes. The light oligodendrocytes are the largest cells 
in the series and have a cytoplasm rich in organelles and 
microtubules suggesting high metabolic activity (Federoff, 1985). 
Federoff also points out that the formation of light 
oligodendrocytes corresponds roughly to the time of rapid 
myelination. After 4-7 days the light oligodendrocytes are 
transformed/ 
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Fig. 4. EM picture of an oligodendrocyte from kitten 
spinal cord extending a process thal branches 
to myel1nate two axons (i\). (N) Nucleus. 
Scale bar: l m x 15,000. From Raine (1984a). 
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transformed into medium oligodendrocytes and these cells appear to 
be less active metabolically. Around two weeks later maturation 
into the dark oligodendrocyte occurs. These cells have dense 
nuclei and cytoplasm and microtubules are difficult to see. Imamoto 
et al. (1978) have proposed that these cells, appearing even less 
metabolically active than medium oligodendrocytes, are involved only 
in the maintenance of the myelin sheath. 
Ultrastructural studies of mature oligodendrocytes have also 
shown that there are two specific loci in the brain where they can 
be found (reviewed by Peters et al., 1976). They are found either 
lying in rows between the axon bundles (interfascicular 
oligodendroglia) or in grey matter as perineuronal cells where the 
cell body is adjacent to a neuronal soma. These studies have also 
shown that these cells exhibit conunon features independent of 
sub-type and location. Since an oligodendrocyte can ensheath many 
axons (up to fifty) its replacement must involve considerable 
disturbance to the glial-axon arrangement and it could be argued 
that any turnover of the adult oligodendroglial population should be 
slow (Sturrock, 1985). Autoradiographic data indicate that in adult 
mice oligodendroglial turnover is between one and two years (Imamoto 
et al., 1978; Kaplan and Hinds, 1980) and is considerably slower 
than that of the other major glial cell type, the astrocyte 
(Paterson, 1983) . 
(b) Differentiation In Vitro 
Although .!J! vivo studies of oligodendrocytes have furnished us 
with knowledge of the general timetable and descriptive aspects of 
oligodendrocyte development and function relatively little 
information/ 
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information has appeared about what factors influence 
oligodendrocyte differentiation. In recent years the development of 
cell culture techniques using enriched cultures of oligodendrocytes 
(McCarthy and de Vellis. 1980; Lisak et al .• 1981) have yielded new 
information on oligodendrocyte development. 
Using monolayers of optic nerves. a culture system that 
contains no neurons. Miller et al. (1985) have shown that the rat 
optic nerve contains three types of macroglial cells which develop 
in a strict sequence: Type 1 astrocytes appear first at embryonic 
day 16. oligodendrocytes at birth and Type 2 astrocytes between 
postnatal days 7 and 10. They have also demonstrated that the three 
cell types originate from two distinct precursor cells. one giving 
rise to Type 1 astrocytes and the other, oligodendrocytes and Type 2 
astrocytes which they have called the 0-2A progenitor cell. The 
presence or absence of foetal calf serum in the medium has a direct 
effect on the 0-2A developmental pathway. 
In the absence of foetal calf serum most cells develop into 
oligodendrocytes (Raff et al .• 1983). 0-2A progenitor cell 
proliferation in vitro is affected by a growth factor produced by 
Type 1 astrocytes (Noble and Murray. 1984) and further work by Raff 
et al. (1985) has suggested the existence of an intrinsic clock in 
the 0-2A progenitor cell that counts cell divisions that are driven 
by the Type 1 astrocyte growth factor. In vitro the 0-2A progenitor 
is a bipolar migratory cell which expresses gangliosides on its 
surface and the intermediate filament protein vimentin in its 
cytoplasm (Raff et al .• 1984). 
The Type 2 astrocytes derived from this lineage contribute to 
the/ 
the Nodes of Ranvier (ffrench-Constant et al .• 1986; 
ffrench-Constant and Raff. 1986). The pattern of incorporation of 
lipid precursors into myelin-related lipids mimicks the time scale 
of development (Ayliffe et al .• 1984) as does the expression of the 
myelin-related lipid and protein markers galactocerebroside (GC) 
(Hirayama et al .• 1984) and CNPase (Roussel et al .• 1983). The 
expression of KBP. usually in cells with more elaborate processes. 
is generally considered a further step in maturation (Roussel et 
al .• 1981). This view has been supported by the fact that. in 
culture. all GCt cells can incorporate C3HJ thymidine whereas 
t + 
only a few GC /MBP can (Bologa et al .• 1983; Roussel et al .• 
1983). Furthermore. cells which were strongly positive for KBP did 
not incorporate C3HJ thymidine at all. 
The exact mechanisms which underlie oligodendrocyte 
differentiation are still unclear. Temple and Raff (1986) have 
proposed that 0-2A progenitor cells can only undergo a limited 
number of divisions (influenced by the Type 1 astrocyte growth 
factor) before they differentiate into oligodendrocytes. This 
hypothesis is supported by evidence that a single optic nerve 
progenitor cell divides a finite number of times on a Type 1 
astrocyte monolayer before its progeny become multipolar cells most 
of which start to express GC after 10-12 days (Temple and Raff. 
1986). 
By studying the development of single progenitor cells for 
three weeks Dubois-Dalcq (1987) has shown that two antigenically 
different populations of cells emerge: non-proliferating GCt 
oligodendrocytes and slow proliferating GC- multipolar cells which 
express/ 
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express a cell surface protein, o4 , shortly before GC. This cell 
population requires specific signals provided by insulin and/or 
neurons for entry into final differentiation. 
Tissue culture studies of myelination by mature 
oligodendrocytes are discussed in Section 1.4 ii (c). 
1.3 BIOCHEMISTRY OF CNS KYELIN 
i. CNS Myelin Lipids 
(a) Composition 
The dominant chemical feature of CNS myelin is the 
characteristically high lipid to protein ratio (Table 1). In the 
rat, some 25~ of the dry weight of brain is accounted for by myeltn, 
and because of the relative excess of lipids in this membrane 
compared to other subcellular fractions of the brain, 40~ of the 
total lipid of brain is accounted for by myelin. In humans, where 
rather more of the dry weight of brain is due to myelin (35~) more 
than half of brain lipid is derived from this membrane (Norton, 
1981). The most quantitatively significant lipids found in myelin 
include cholesterol, cerebroside and the plasmalogen form of 
ethanolamine. Of note is the presence of sulphatide 
(cerebroslde-3-sulphate), a galactolipid, whilst not being entirely 
specific for the myelin membrane is considerably enriched with 
respect to other cellular membranes. Cerebroside and sulphatide are 
characterized by very long chain saturated and monoenoic fatty acids 
and Vandenheuval (1963) has suggested that this gives the myelin 
membrane increased stability. The phospholipids phosphatidylserine, 
phosphatidylcholine, sphingomyelin and phosphatidylethanolamine are 
less/ 
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TABLE 1 COMPOSITION OF MATURE CNS .KYELIN FROM SEVERAL 
SPECIES (Norton, 1981) 
Components Human Bovine 
('I. of dry weight) 
Protein 30.0 24.7 
Lipid 70.0 75.3 
('I. of lipid weight} 
Cholesterol 27.7 28.1 
Total Galactolipid 27.5 29.3 
Cerebroside 22.7 24.0 
Sulphatide 3.8 3.6 
Total Phospholipid 43.1 43.0 
Ethanolami ne a 15.6 17.4 
Choline 11.2 10.9 
Serine 4.8 6.5 
Inositol 0.6 0.8 
Sphingomyelin 7.9 7.1 
a Primarily ethanolamine plasmalogen 
Rat 
29.5 
70.5 
27.3 
31.5 
23.7 
7.1 
44.0 
16.7 
11.3 
7.0 
1.2 
3.2 
less prominent in myelin than other membranes. Several minor lipid 
constituents found in myelin (particularly gangliosides) have 
attracted much attention since it is thought that they may have some 
dynamic function as opposed to the purely structural roles 
attributed to the major myelin-containing lipids. Around 0.2~ of 
myelin lipid is composed of gangliosides (sialic acid - containing 
glycosphingolipids) primarily the monosialoganglioside GKl (Ledeen 
et al .• 1980). Cochran et al. (1982), amongst others. have found 
that in addition to GK1 • higher primates and birds also contain 
sialosylgalactosylceramide (GK4 or G7 ); this lipid appears to be 
specific for myelin and oligodendrocytes. Sialic acid is thought to 
play a role in cell-cell recognition and communication and it has 
been suggested that these gangliosides many serve some similar 
function during development of the myelin sheath (Wiegandt, 1982). 
(b} Metabolism 
All the available evidence to date has shown that the 
biosynthetic pathways for CNS myelin lipids do not differ 
significantly from those found in other tissues, however these 
pathways must be extraordinarily active (Morrell and Toews. 1984). 
It is generally assumed that the accumulation of "myelin 
specific" lipids (cerebroside and sulphatide are the most specific 
markers used) in the brain correlates with the time when 
oligodendrocytes are most active in synthesizing myelin. Studies in 
vivo using radioactive precursors of cerebroside and sulphatide have 
shown that incorporation of label increases as myelination begins. 
remains high during the period of active myelination and decreases 
as the rate of myelination decreases (Kishimoto et al .• 1965; KcKhann 
and/ 
31 
and Ho, 1967). Galactosylation of ceramide and sulphation of 
cerebroside in vitro correlate well with the in vivo studies, the 
peak of enzyme activity corresponding to the peak rate of myelin 
accumulation (Constantino-Ceccarini and Morell, 1972). 
The presence of various lipid-synthesizing enzymes in CNS 
myelin has received much attention recently and confounds the view 
that the myelin sheath is essentially an inert structure (reviewed 
by Ledeen, 1984). A high ethanolamine kinase activity has been 
found in purified myelin (Kunishita et al., 1987) and has completed 
the list of pbospholipid synthesizing enzymes needed to synthesize 
phosphatidylethanolamine from diacylglycerol within the myelin 
membrane, CDP-ethanolamine:1, 2-diacyl-sn-glycerol 
ethanolaminephosphotransferase and CTP:phosphoethanolamine 
cytidylyltransferase having already been discovered (Wu and Ledeen, 
1980; Kunishita and Ledeen, 1984). High levels of long-chain 
acyl-CoA synthetase, an enzyme that is involved in fatty acid 
incorporation into phospholipids and other lipids, has also been 
detected in purified myelin by Vaswani and Ledeen, (1987) and their 
results suggest the presence of different synthetases for 
arachidonate and oleate, analogous to the phenomenon reported in 
other tissues (Laposata et al., 1985). 
In turnover studies on myelin lipids it bas been observed that 
inmediately following the period of maximal incorporation of a 
precursor in a given lipid there is a relatively fast metabolic 
decay, the half-life increasing as the time after injection 
increases. This observation has led to two hypotheses. One 
interpretation is that newly synthesized lipids not yet buried deep 
within/ 
32 
within the myelin sheath are more accessible to catabolic enzymes 
involved in lipid turnover. This view has been supported by Killer 
and Morell (1978) using older animals where myelin accumulation is 
much slower. In this experiment only the rapid turnover phase was 
detected. The hypothesis of Freysz and Mandel (1980) argues that 
the rapidly turning over pool represents lipids at the major dense 
line (cytoplasmic face) and are more likely to come into contact 
with degrGdation enzymes in the cytoplasm. The stable lipid pool 
consists of lipid at the intraperiod line separated from the 
cytoplasmic face by the energy barrier of flipping from one bilayer 
leaflet to the other (flip-flop). 
In young animals both lipid pools would be labelled since 
myelin is accumulating at a rapid rate, in older animals the 
cytoplasmic-face lipids would be preferentially labelled but would 
also be degraded rapidly. 
For myelin lipids to be turned over presents a unique 
problem. Lateral diffusion to a specialized region of the sheath, 
for example the Schmidt-Lanterman Incisures, must take place since 
radial diffusion through consecutive layers of membrane seems 
unlikely on thermodyn&Jnic grounds. Once lipids have reached the 
cytoplasmic-containing areas of the sheath there is no evidence to 
suggest that significant catabolism takes place there. Therefore it 
is thought that the lipids have to travel all the way back to the 
oligodendrocyte perikaryon (an area midway between the cell body and 
the compact sheath) for degradation to take place. It is perhaps 
not surprising then, that lipid turnover is somewhat slower in 
myelin than in other biological membranes (Morell and Toews, 1984). 
ii./ 
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ii. Major Proteins of CNS Kyelin 
CNS myelin is unique not only because of the high lipid to 
protein ratio by comparison with other cell membranes but also 
because of its relatively simple protein composition when analysed 
by SOS-PAGE (see Results Section). Historically the protein 
composition has been divided into a low molecular weight group which 
includes MBP and PLP and a high molecular weight ()40k.Da) region 
containing, amongst many minor protein bands, CNPase and MAG. 
Indeed, it has been calculated that these four protein species alone 
account for around 801. of total myelin protein (Eylar, 1972). 
However, despite a wealth of biochemical knowledge that has 
developed over the years, no single function has been attributed to 
any of the proteins and their individual role in myelin formation 
and stabilization remains obscure. 
(a) Proteolipid Protein (PLP) 
PLP, also known as lipophilin (Boggs et al., 1976) is the 
major integral membrane protein in the myelin sheath, in some 
species accounting for as much as 501. of total myelin protein. The 
term proteolipid was c~ined by Folch and Lees (1951) to describe a 
class of myelin proteins that were soluble in organic solvents and 
insoluble in aqueous media even when devoid of associated complex 
lipids. Subsequently it has been shown that the lipid-free 
apoprotein can be converted to a water soluble form (Lees et al., 
1979), however classical methods of purification still involve 
extraction into chloroform-methanol. Cambi et al. (1983) have shown 
that the only protein found in chloroform-methanol extracts of 
bovine brain white matter was PLP. The protein has an apparent 
molecular/ 
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molecular weight of 24-26k.Da by SDS-PAGE although protein sequencing 
data of bovine PLP (Lees et al .• 1983; Stoffel et al .• 1983) and the 
amino acid sequence derived from rat brain cDNA clones (Milner et 
al .• 1985; Dautigny et al .• 1985; Naismith et al .• 1985) shows that 
the protein has a true molecular weight of almost eiactly 30ltDa. 
PLP and its proteolytic fragments have a strong tendency to 
aggregate and precipitate in aqueous solutions due to their 
hydrophobic properties and this hampered protein sequencing 
studies. Eiamination of the amino-acid sequence (Figure 5) shows a 
sharp segregation into hydrophobic and hydrophilic domains. 
Sequence homology between the bovine and rat protein is very high. 
between 97-99~. and such an eitreme conservation suggests a very 
strong structure/function relationship for PLP. Both bovine and rat 
PLP contain 14 cysteine/half-cysteine residues but only 25-30~ react 
with sulphydryl reagents (Cockle et al .• 1980) suggesting that the 
remainder form five disulphide bonds. From the sequence data a 
model can be constructed for the conformation of the protein within 
the lipid bilayer (Figure 6). The essential features of the model 
are 1) 3 transmembrane segments traversing the lipid bilayer. 2) 2 
cis-membrane domains. eitracellularly orientated and 3) 1 highly 
charged domain on the cytoplasmic side. The els-membrane domains 
could promote. via hydrophobic interactions with the bilayer across 
the extracellular space. the formation and stabilization of the 
multilamellar myelin structure (Laursen et al •• 1984). 
PLP is not a glycoprotein (unlike the major integral membrane 
protein of PNS myelin. Po) but it is acylated, containing two 
molecules of palmitic acid per polypeptide chain (Stoffyn and 
Folch-Pi. 1971). Indeed. PLP was the first protein reported to 
contain/ 
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contain covalently bound fatty acids, a post-translational 
modification now recognized as widespread amongst membrane proteins 
(Schmidt, 1983). Bizzozero and Lees (1986) have identified 
palmitoyl-CoA as the lipid donor in purified myelin. The biological 
role of the esterified palmitic acid is unknown; since this confers 
increased hydrophobicity to PLP it may be important in maintaining 
lipid-protein interactions necessary for myelin stability. 
The clone isolated by Kilner et al. (1985) recognized two 
mRNAs of 3.2 and 1.6kb that encode PLP. Both mRNAs are the product 
of one PLP gene and arise from alternative recognition of two 
polyadenylation sites. Kilner and colleagues also find no evidence 
of a cleavable amino-terminal signal sequence for PLP. This is 
somewhat unusual for an integral membrane protein and suggests that 
the insertion of the protein into the membrane during biosynthesis 
involves either a non-cleaved N-terminal signal or an internal 
signal sequence (Section 1.4 i). 
A closely related protein which crossreacts with PLP antiserum 
is also present in CNS myelin. This protein (DK20) is much less 
abundant than PLP and has an apparent molecular weight of 20k.Da as 
judged by SOS-PAGE. DK20 has been shown to share most structural 
and chemical properties with PLP, including amino-terminal 
sequences, carboxyl-terminal residue and amino-acid composition 
(Lees and Brostoff, 1984) and was thought, at that time, to be a 
deletion product of PLP. This has been verified by Nave et al. 
(1987) who have shown that DK20 is translated from an alternatively 
spliced mRNA lacking the coding region for residues 116-151 in the 
rat protein (Figure 7). Interestingly, the intron-exon structure of 
the/ 
the PLP gene (Diehl et al .• 1986) shows that this arises by the 
selection of 5' splice donor sites rather than by the much more 
common process of independent exon splicing. Thus the PLP 
transcript utilizes alternative splicing to generate internal 
variants with altered coding capacities. 
(b) Kyelin Basic Proteins (KBPs) 
KBPs are a family of highly charged peripheral or extrinsic 
membrane proteins and together constitute about 30~ of total CNS 
myelin protein although this figure has been challanged recently. 
Careful dye-binding experiments using purified KBP have set the 
percentage at around 10 (Brophy et al., unpublished results). The 
proteins are easily extracted by acid and four KBPs can be 
recognised in rodents having molecular weights of 21.SkDa 
(pre-large), 18.SkDa (large), 17kDa (pre-small) and 14kDa (small) 
(Barbarese et al., 1977) with the two pre-species being present in 
smaller amounts than either the large or small KBP. Interestingly, 
the relative ratios of these proteins changes through development. 
In the young animal the ratio is 1:5:2:10 and in an adult 
1:10:3.5:35 (Barbarese et al .• 1978). Newman et al. (1987) have 
recently identified a second 17k.Da protein by cDNA cloning which 
appears to be expressed at a lower level than the more widely 
characterized varient. 
In humans, the presence of at least three KBP varients with 
molecular weights of 21.5, 18.5 and 17.3kDa have been reported 
(Deibler et al., 1986; Roth et al., 1986). To complicate the issue 
even further, a fourth human KBP of 20.2k.Da has recently been 
discovered (Roth et al., 1987). All the MBPs are structurally and 
antigenically/ 
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antigenically related and are the product of only one gene (de Ferra 
et al .• 1985; Takahashi et al .• 1985). In rodents the 32kb MBP gene 
is composed of seven exons and alternative splicing gives rise to 
each individual protein species (Figure 8). Identical MBPs are 
found in the PNS and Mentaberry et al. (1986) have shown that the 
same gene is responsible for the expression of these proteins. A 
23k.Da KBP which appears to be translated from a mRNA that is not a 
precursor to the other forms of ftBP has recently been discovered in 
rat brain (Agrawal et al., 1986). The 21.Slt.Da MBP contains all the 
sequences found in the other basic proteins and the latter can be 
generated by splicing out exons 2 (18.5k.Da), 6 (17k.Da) or both 
(14k.Da). Sequence homology between species is less than that of 
PLP. with rat and bovine ftBP having 90~ conservation. Several cDNA 
and genomic clones of MBP exist (Takahashi et al., 1985; de Ferra et 
al .• 1985) and examination of the sequence (Figure 9) reveals no 
cysteinyl residues present therefore there is no capacily for 
intramolecular disulphide bridge formation. Although the basic 
protein is essentially a random coil in solution it is not 
completely without organization and there exist definite regions of 
localised structure (ftendz et al .• 1982; Stoner, 1984). 
The proposed folding of the protein is thought to arise from a 
hairpin structure (Stoner. 1984) and most of the ordered 
conformation is in the form of p-turns which overlap extensively 
resulting in a flat, pleated sheet-like structure (Martenson, 
1981). The cationic residues in this configuration are ideally 
orientated for interaction with the phosphate groups of lipids at 
the cytoplasmic surface. Recent evidence has suggested. however. 
that/ 
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Fig. 9. Amino acid sequence of rat brain small MBP. 
that KBP-lipid interactions may not be restricted to only 
electrostatic forces since it is thought a covalent linkage of 
polyphosphoinositide to Ser-54 of bovine MBP exists (Chang et al .• 
1986). This has been disputed recently by Smith et al. (1987) who 
have shown that MBP contains less than 4mol ~ of inositol and that 
the stoichiometry rules out a general mechanism for attachment of 
this cytoplasmically-orientated protein to its membrane. The amino 
acid sequence also reveals several other interesting features. 
There is an unusually high percentage (24~) of basic residues and 
apart from Lys and Arg the His content is much higher than in most 
proteins. Furthermore. the basic residues appear to be randomly 
distributed along the polypeptide chain {Lees and Brostoff. 1984). 
Most of the glutamic acid residues are amidated giving rise to the 
very high isoelectric point of.> 10. There is a single Trp present 
and it is thought that the sequences around it serve as a focal 
point for the k.nown encephalitogenic properties of the protein 
(Eylar et al .• 1970). 
MBPs are not glycoproteins in vivo although the proteins have 
been shown to be acceptors of N-acetylgalactosamine when incubated 
with the appropriate galactosyl transferase in vitro (Cruz and 
Moscarello. 1983). Cruz et al. (1984) have identified the 
glycosylation site in human MBP to be Thr-95. 
Three different post-translational modifications of MBPs have 
been discovered; methylation. acetylation and phosphorylation. In 
the course of determining the sequence of CNS KBP from bovine and 
human sources it soon became apparent that Arg-106 was methylated 
(Eylar et al .• 1971). Further biochemical analysis has shown that 
both/ 
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both monomethyl and dimethylargini~are present and that the process 
is enzymatic and occurs at only one position in the molecule 
(Baldwin and Carnegie, 1971). 
The role of methylation is unknown, however Crang and Jacobsen 
(1982) have demonstrated that methylation increases during 
myelination suggesting it is important in myelin formation. 
Labelling studies have recently shown a high rate of KBP methylation 
during synthesis in the brains of young mice, decreasing as the 
animals matured (Chandekar et al., 1986). Acetylation, the second 
post-translational modification, is confined to the N-terminal Ala 
in all species so far examined. 
Phosphorylation of KBPs has been shown both in vivo and in 
vitro (Martenson et al., 1983; Kobayashi, 1984). Although its 
significance remains unclear it has been speculated that MBP 
phosphorylation might destabilize the compact myelin lamellae 
structure by causing a reversible separation of apposed cytoplasmic 
faces (the major dense line) at discrete areas of the sheath (Turner 
et al., 1984). If this is the case then the regulation of MBP 
phosphorylation and dephosphorylation would clearly play a pivotal 
role in the stabilization of the myelin structure. Phosphorylation 
of KBP in vivo is rapid with a turnover rate in the order of minutes 
(Des Jardins and Morell, 1983) however, only a small percentage of 
MBPs are in the phosphorylated form in vivo (Martenson et al., 
1983). These observations also suggest a role for phosphatases in 
the regulation of myelin functions and the presence of an endogenous 
CNS myelin protein phosphatase (LP2) has recently been discovered 
(Yang et al., 1987). 
Two/ 
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Two reports have been published which show that KBP can 
interact in vitro with elements of the cellular cytoskeleton. In 
their study. Barylko and Dobrowolski (1984) found that when purified 
KBP was added to filamentous actin (F-actin) a complex of both 
proteins was precipitated. These authors suggest that either the 
contractile proteins are involved in transporting the KBPs to the 
membrane (Section 1.4 ib) or the KBP-associated microfilaments have 
a direct role in oligodendrocyte process formation itself. 
particularly since the microfilament-disrupting drug cytochalasin 
has been shown to cause unusual morphological changes in cultured 
oligodendrocytes (Kumagai et al., 1986). That KBP interacts with 
tubulin has been shown by Kodesti and Barra (1986) and may be of 
significance in vivo since it is known that tubulin is a component 
of CNS myelin (de Nechaud et al., 1983). 
(c) 2', 3'-Cyclic Nucleotide 3'-Phosphodiesterase (CNPase) 
This enzyme (EC 3.1.4.37). which appears as a doublet on 
SOS-PAGE. was first demonstrated in bovine spleen (Whitfeld et al., 
1955) and pancreas (Davis and Allen, 1956) but was later found at a 
much higher specific activity in the brain (Drummond et al .• 1962) 
where it is primarily associated with myelin (Kurihara and Tsukada, 
1967). CNPase activity is highest in the Corpus Callosum, an area 
of high activity and extensive myelin deposition (Kurihara and 
Takahashi. 1973). CNPase has recently been shown to be present at 
low activity in bovine adrenal medulla (Tirrell and Coffee. 1986), 
rat lymphoid tissue (Sprinkle at al., 1985). rat thymus and 
circulating blood lymphocytes (Bernier et al .• 1987). 
The CNPases were formerly called the Wolfgram proteins (Wl and 
W2)/ 
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W2) after Wolfgram and Kotorii (1968) who concluded on the basis of 
differential amino acid analyses that a third major protein 
fraction. rich in dicarboxylic acids, exists in CNS myelin besides 
PLP and ftBP. For many years the exact number and molecular weights 
of bands corresponding to CNPase were debated culminating in an 
extensive electrophoretic study by Waehneldt and ftalotka (1980) who 
conclusively showed that CNPase (still called Wolfgram protein) 
consisted of a doublet in all mammalian species studies. The 
relative amounts of CNPase I and CNPase II vary with species as does 
the difference in molecular weight as established by SOS-PAGE. The 
rat enzymes have the highest apparent molecular weight (47k.Da and 
49k.Da) for CNPase I and II respectively with the lowest molecular 
weight species present in human myelin (42kDa and 45kDa). The 
proteins are thought to be subunits of the native enzyme since 
electrophoresis in non-denaturing conditions puts the molecular 
weight at around lOOk.Da (Sprinkle et al .• 1980). These workers and 
others (DrUJm1ond and Dean, 1980) have clearly shown by 
immunological. electrophoretic and amino acid compositional analysis 
that Wolfgram protein W1 and CNPase I are identical as are W2 and 
CNPase II. 
Although the enzyme's existence in CNS myelin has been known 
for some time (Kurihara and Tsukada, 1967) it is only within the 
last 10 years that CNPase has been purified. This is, in part. due 
to the enzyme's strong binding to the membrane and the requirement 
for rather drastic solubilization procedures, for example detergent 
or guanidine as a pre-purification step (Drummond, 1979; Suda and 
Tsukada, 1980; Wells and Sprinkle, 1981). CNPase hydrolyzes, in 
vitro,/ 
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vitro, 2' 3'-cyclic nucleotides to form 2'-nucleotides (Figure 10) 
and thin-layer chromatography has shown that only the 2'-isomer is 
produced (Sheedlo et al., 1984). It has also been shown that CNPase 
does not require divalent cations for activity and that the purified 
enzyme from human and bovine myelin has the very high specific 
activity of 1000-4400 pmoles of 2' 3'-cyclic AMP/min/mg protein. 
The enzymatic activity for CNPase is unusual for two reasons. 
Firstly, 2' 3'-cyclic nucleotides are known to be enzymatic 
breakdown products of RNA and may be involved in RNA processing and 
splicing reactions, however 2', 3'-cyclic nucleotides are not known 
to accumulate in cells to any great degree (Olafson et al., 1969). 
Indeed, hydrolysis of these substrates is not confined exclusively 
to CNPase although CNPase is the only enzyme which converts them to 
2'-nucleotides. Whether 2', 3'-cyclic nucleotides are the natural 
substrate is unknown as is the physiological role of CNPase. Two 
groups (Nakamura et al., 1979; Vogel and Thompson, 1986) have 
partially purified a nucleotide phosphomonoesterase from brain which 
is specific for 2'-nucleotides and this has led to the proposal of a 
pathway whereby the 2'-nucleotidase hydrolyzes the products of the 
CNPase reaction (Takahashi, 1981) (Figure 11). On a different line 
of investigation Sprinkle et al. (1987) have recently found a 
5'-polynucleotide kinase activity associated with bovine and human 
CNPase. Purified wheatgerm and yeast RNA ligases have been shown to 
exhibit 2', 3'-cyclic nucleotide phosphosphodiesterase, ligase and 
5'-polynucleotide kinase activities all residing in a single 
polypeptide chain (Phizicky et al., 1986; Pick and Hurwitz, 1986). 
The findings of Sprinkle et al. (1987) have led them to suggest 
that,/ 
45 
() 
HO O 
I 
HO-P-0 
I OH 
Fig. 10. Enzyme reaction catalysed by CNPase. 
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Fig. 11. Proposed pathway for the hydrolysis of the 
products of the CNPase reaction. After 
Takahashi (1981). 
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sequence is shown in bold type. After 
Bernier et al. (1987). 
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that, since CNPase displays two out of the three enzyme activities 
associated with RNA ligases, the natural substrate for CNPase may be 
RNA and that the enzyme is involved in RNA metabolism. CNPase has 
recent!~ been cloned from bovine (Vogel and Thompson, 1987; Kurihara 
et al., 1987) and rat brain (Bernier et al., 1987). The bovine 
clone codes for CNPase II and contains 400 amino acids, MW 44875Da, 
while that of rat brain is for CNPase I (404 amino acids, MW 
45592Da). Interestingly both clones code for the CNPase species 
that is most abundant in the respective doublets, bovine being the 
only m8Jllllalian species so far studied that has a greater amount of 
CNPase II than I (Waehneldt and Malotka, 1980). Examination of the 
sequence from the rat brain clone (Figure 12) reveals that many of 
the acidic amino acids are amidated giving rise to the published 
isoelectric point of 8.5-9.0 for the purified rat enzyme (Wells and 
Sprinkle, 1981). 
CNPase II has been shown to be phosphorylated in vitro in a 
cyclic-AMP and Ca2~ dependent manner by an endogenous myelin 
kinase (Bradbury and Thompson, 1984). As with KBP the turnover rate 
of this phosphorylation.!.!!. vivo is rapid suggesting a physiological 
role for this post-translational modification. Vogel and Thompson 
(1987) have tentatively identified Ser-74, Ser-177 and Ser-305 as 
possible phosphorylation sites. In their rat brain clone Bernier et 
al. (1987) have identified a sequence (amino acids 69-81) that is 
homologous to known sites for cyclic nucleotide binding in other 
proteins. Northern blot analysis has failed to demonstrate whether 
there are two distinct mRNAs for each CNPase polypeptide, however an 
apparently single mRNA species from rat thymus has been shown to 
code/ 
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code for both proteins {Bernier et al., 1987). These workers also 
provide evidence for a single CNPase gene and the idea that the 
proteins differ only be some form of post-translational modification 
{other than phosphorylation) is gaining ground. 
{d) ftyelin-Associated Glycoprotein (ft.AG) 
The fourth most abundant protein of CNS myelin, ftAG, accounts 
for about l~ of total myelin protein {Quarles et al., 1972). 
Several glycoproteins have been identified in CNS myelin on the 
basis of lectin-binding, fucose incorporation and periodic 
acid-Schiff staining but ft.AG is by far the most prominent (Poduslo 
and Braun, 1975). ft.AG has been purified from the 
chloroform-methanol insoluble residue of myelin by solubilization 
with the surface-active agent lithium diiodosalicylate, followed by 
phenol extraction {Quarles and Pasnak, 1977; Quarles et al., 1983). 
It is an integral or intrinsic membrane protein with an apparent 
molecular weight of lOOkDa as judged by SOS-PAGE. The protein is 
almost one-third carbohydrate by weight and has a sugar composition 
similar to other glycoproteins with N-linked oligosaccharides. The 
sugars present are fucose {5~), mannose (23~). galactose (20~). 
N-acetylglucosamine (34~) and N-acetylneuraminic acid (sialic acid) 
(18~) (Quarles et al., 1983). ft.AG is also sulphated, probably on 
the sugar residues, as demonstrated by the incorporation of c35s1 
sulphate in vivo (Ratthieu et al., 1975). The protein has not been 
shown to be phosphorylated either in vivo or in vitro although a 
putative site for phosphorylation by a tyrosine kinase has been 
identified (Lai et al., 1987). Two ft.AG polypeptides are detectable 
in in vitro translation systems {Frail and Braun, 1984). The 
proteins/ 
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proteins (72k.Da and 67k.Da) once glycosylated are presumed to 
co-migrate on SOS-PAGE as the characteristically broad band at 
lOOk.Da. The precise structural differences between the proteins 
have recently been elucidated (Lai et al., 1987). Earlier work had 
shown that peptide maps of both proteins were nearly identical 
(Frail and Braun, 1984). These workers have also shown that the 
mRNA for each MAG protein is developmentally regulated. 72k.Da MAG 
(or L-KAG) mRNA appears at an earlier age than 67k.Da MAG (S-MAG) and 
remains the dominant MAG mRNA species throughout the period of rapid 
myelination. As the rate of myelination decreases S-MAG mRNA 
becomes the dominant MAG mRNA species. This phenomenon was first 
observed by Quarles et al. (1973) where they measured the rate of 
incorporation of radiolabelled fucose into rat brain of various 
ages. KAG bas recently been cloned (Lai et al., 1987; Salzer et 
al., 1987; Arguint et al., 1987) and all the clones isolated 
hydridize to two distinct mRNAs supporting the earlier in vitro 
translation results. The two KAGs share a common 23 amino acid 
membrane spanning domain but differ in the structure of their 
C-termini. Of particular interest is the tripeptide Arg-Gly-Asp 
(residues 118-120, Figure 13), located at the potentially 
extracellular disposed N terminus, which has been shown to be a 
crucial element in the interaction of a growing number of cell 
surface receptors, such as the fibronectin receptor (Tamkun et al., 
1986) and the receptor for vitronectin (Pytela et al., 1985), with 
extracellular proteins. Of additional interest since MAG is thought 
to participate in myelin-axon recognition (Section 1.2 ii) is the 
finding that there is very strong homology between MAG and N-CAM, a 
well/ 
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Fig. 13. Amino acid sequence of L-MAG. The 
tripeptide RGD is underlined and 
the potential transmembrane segment 
is shown in bold type. After 
Salzer et al. ( 1987). 
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Model of MAG showing the 
multiple domain structure. 
After Salzer et al. (1987). 
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Fig. 15. MAG gene and transcript structure. Protein coding 
regions of the spliced exons are shaded. 
well characterized cell adhesion molecule in the vertebrate nervous 
system which is thought to mediate neuron-neuron interactions 
(Edelman, 1984). Salzer et al. (1987) have concluded from their 
deduced amino acid sequence of L-RAG that there are five segments of 
internal homology each of which contain sequences that resemble 
those of i11111unoglobulin domains and they have classified KAG as a 
member of the i11111unoglobulin gene superfamily. These proteins all 
share a connon extracellular subunit structure termed the 
i11111unoglobulin homology unit (Hunkapillar and Hood, 1986). The 
significance of this shared structure is not understood. A proposed 
model for RAG is shown in Figure 14. Both Salzer et al. (1987) and 
Lai et al. (1987) have provided evidence that a single gene for MAG 
exists and that, like PLP, DK20 and KBPs. the different forms of MAG 
arise from alternative splicing of the primary transcript (Figure 
15). Of considerable interest has been the discovery that there is 
a shared antigenic determinant between human MAG and Leu-7 (HNK-1). 
a surface marker of human natural killer (NK) cells (KcGarry et al., 
1983; Murray and Steck. 1984). It is thought that this may be of 
significance with regard to autoimmune demyelination diseases since 
Tanaka et al. (1985) have shown that NK activity is reduced by the 
treatment of anti-RAG antibodies in vitro. 
(e) P2 Protein 
The P2 protein is a basic protein of apparent molecular weight 
14tDa. The protein is most abundant in the PNS and was once thought 
to be a PNS-specific protein however immunological techniques have 
shown that it is present at decreased amounts in bovine. human and 
rabbit spinal cord (Uyemura et al., 1977), rabbit oligodendrocytes 
(Trapp et al., 1983) and areas of bovine brain associated with motor 
functions./ 
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functions. P2 is not found in the higher areas of the CNS. optic 
nerve or non-neural tissue (Eaton et al .• 1984). The amount of P2 
found in CNS tissue is curiously variable from species to species 
and it has not been detected in the CNS of rodents (Kadlubowski et 
al .• 1984). The variable amounts of P2 may be related to the 
observation that it is not a component of all nerve fibres but 
instead is present in some fibres and absent from others. also the 
proportion of fibres containing P2 tends to be larger in more caudal 
parts of the CNS (Trapp et al .• 1983). The significance of this 
variation in distribution is not known however it raises the 
interesting question of variations in structure and even functions 
of myelin from different regions of the CNS. 
The complete amino acid sequence of bovine (Kitamura et al .• 
1980). rabbit (Ishaque et al .• 1982) (Figure 16) and human (Suzuki 
et al .• 1982) P2 is known and each protein contains 131 amino acids 
differing by substitutions at nine locations. It has a lower 
percentage of basic amino acids (19~} than KBP but contains a higher 
percentage of hydrophobic amino acids leading to the suggestion that 
its interaction with the myelin membrane involve fewer 
electrostatic but more hydrophobic forces than for KBP (Lees and 
Brostoff. 1984). The membrane interaction is weak however since P2 
can be isolated from non-delipidated myelin using extremely mild 
salt or acid conditions (Uyemura et al .• 1977). P2 has an extensive 
p-sheet secondary structure and a virtual absence of~-helix and 
three possible structural models have been put forward by Martenson 
(1983) all essentially consisting of eight antiparallel p-strands 
with a two-stranded ribbon of antiparallel p-structure emerging from 
one/ 
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Fig. 16. Amino acid sequence of rabbit P2 protein. 
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one end (Figure 17). A striking sequence homology has been noticed 
between P2 and lipid-binding proteins from rat heart (Sacchettini et 
al .• 1986). murine adipocytes (Bernlohr et al .• 1984) and the 
cellular retinoid binding proteins (Takahashi et al .• 1982). These 
proteins all have similar molecular weights and amino acid 
compositions and this has led to the suggestion that P2 may be a 
member of a group of intracellular proteins with a high affinity for 
lipids and a similar function (Lees and Brostoff, 1984). Since P2 
is an extrinsic-type membrane protein as judged by the ease of 
extraction from the myelin membrane, it is conceivable that P2 has a 
role as a lipid carrier. 
An important discovery was made in 1979 when Kadlubowsky and 
Hughes were able to induce experimental allergic neuritis (EAN) in 
Lewis rats by the administration of P2. Following on from this 
initial discovery Ishaque et al. (1981) were able to show that P2 
was much more innunogenic when complexed with phospholipids 
indicating that the antigenic domain requires these lipids in order 
to attain the most favourable conformation for inducing a 
cell-mediated response that leads to disease. EAN is important 
because it is thought to be very similar to the human Guillain-Barre 
syndrome, an autoinnune demyelinating disease that specifically 
affects the PNS (Raine. 1984b). 
1.4 CELL BIOLOGY OF JIYELINATION IN THE CNS 
i. Current Theories of ftembrane Protein Biosynthesis 
(a) Intrinsic ftembrane Proteins 
The unique orientation of intrinsic plasma membrane proteins 
within/ 
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within the lipid bilayer with apolar residues interacting with lipid 
in the core of the bilayer and polar amino acids on both sides of 
the membrane presents an interesting problem for the cell's protein 
synthesis machinery. The apparatus for protein synthesis resides 
exclusively in the cytoplasm of the cell so this must mean that 
polar residues have to cross the lipid bilayer either during or 
after synthesis. yet it is their inability to do this that maintains 
the asynrnetry of proteins within the plasma membrane. This complex 
process was an enigma until cell-free translation systems. assembled 
from heterologous components. were found to be able to reconstitute 
the early events in translocation of the nascent polypeptide through 
the membrane at its site of synthesis. The classic work of Palade 
and his colleagues (Palade. 1975) had shown that newly synthesised 
secretory proteins were initially found within the lumen of the 
rough endoplasmic reticulum (RER) and since then it has been 
conclusively shown that both intrinsic membrane (Lingappa et al .• 
1978) and lysosomal proteins (Erickson et al .• 1981) both utilize 
the translocation machinery inherent in the RER. 
Early studies by Milstein et al. (1972) had shown that larger 
forms of immunoglobulin light chains were synthesized than those 
eventually secreted from the cell and they postulated that the extra 
piece was at the NH2-terminal and that this might serve as a 
signal for insertion into the ER membrane. 
These studies also showed that in the presence of microsornes 
mature-length protein was produced thereby demonstrating that the 
signal sequence was cleaved during translocation into the KKR. 
Further evidence for the existence of a 'signal sequence' in nascent 
polypeptides/ 
polypeptides began to appear (Kemper et al .• 1974, Blobel and 
Dobberstein. 1975a; Blobel and Dobberstein, 1975b) and led to the 
signal hypothesis of Blobel and Dobberstein (1975b), an idea that 
had originally been put forward by Blobel and Sabatini in 1971. The 
essence of the signal hypothesis was that the information 
determining the specific association of polysomes with the RER 
membrane is contained in the amino-terminal portion of the nascent 
polypeptide and that this segment directs polysome-membrane 
attachment and assists in the cotranslational insertion of the 
nascent polypeptide through the microsomal membrane. Folding of the 
polypeptide chain would then serve to draw the remainder of the 
nascent chain through the postulated proteinaceous tunnel in the RER 
membrane. 
Three components of the microsomal translocation apparatus 
have been purified from canine pancreas. the signal recognition 
particle (SRP) (Walter and Blobel. 1980). the SRP receptor also 
known as the docking protein (Gilmore et al .• 1982; Meyer et al., 
1982) and the signal peptidase (Evans et al .• 1986). A fourth 
component of the microsomal translocation machinery has recently 
been discovered. Although the protein has not been purified it is 
known to be an intrinsic membrane glycoprotein of molecular weight 
35kDa and has been named the signal-sequence receptor (SSR) 
(Wiedmann et al .• 1987). 
SRP is a complex of six polypeptides and a 7S RNA whose 
function is to bind to the signal sequence as it emerges from the 
ribosome during synthesis. A chain length of approximately 70 amino 
acids seems to be required before the interaction of SRP and the 
nascent/ 
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nascent polypeptide chain can occur (Reyer et al., 1982) and it is 
known that after binding a temporary translation arrest occurs 
(Walter and Blobel, 1981; Meyer et al., 1982) until the SRP-ribosome 
complex binds to the docking protein located in the RER. The 
resultant attachment of the ribosome to the membrane is accompanied 
by SRP displacement from the ribosome by the docking protein 
(Gilmore and Blobel, 1983) and by a direct interaction between the 
signal-sequence and the SSR (Wiedmann et al., 1987). The ribosome 
is then free to continue chain elongation. The growing polypeptide 
chain passes through the ER membrane into the lumen where the 
cytoplasmically-situated signal peptidase removes the signal 
sequence. These events are depicted in Figure 18a. The mechanism 
of translocation remains unclear at the present time and it is not 
known whether it proceeds through a proteinaceous tunnel or directly 
through lipid (Wickner, 1979). 
Once the polypeptide chain has entered the lumen of the RER 
core glycosylation and disulphide bridge formation can occur via 
enzymes located on the luminal side of the RER and once protein 
synthesis has terminated the ribosome is free to join the soluble 
pool of ribosomes and enter into a further round of protein 
synthesis. The exact route taken by the protein from the lumen of 
the RER to the plasma membrane is still under debate although it is 
presumed to enter the Golgi where trinvning and modification of core 
oligosaccharides take place and is then finally transported via 
Golgi-derived vesicles to its target membrane (Palade, 1975). It is 
thought that the smooth areas of the RER, termed transitional zones, 
are/ 
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are the sites for budding of protein- containing RF.R vesicles and 
Lodish et al. (1987) have succeeded in identifying a vesicle 
fraction that is enroute from the RF.R to the cis face of the Golgi. 
Furthermore, the exit of proteins from the RER has been shown to be 
the step at which maturation of secretory and intrinsic membrane 
proteins is regulated (Fries et al., 1984; Williams et al., 1985). 
Recently it has been shown that translocation-competent 
binding of the ribosome to the ER membrane requires the 
participation of a GTP-binding protein in addition to the SRP and 
the docking protein (Connolly and Gilmore, 1986). These authors 
were also able to show that once the ribosome-membrane complex had 
formed, translocation of the nascent polypeptide through the ER 
membrane did not require GTP hydrolysis. One of the most striking 
features to emerge from these experiments and of central importance 
to the signal hypothesis is the tight coupling of synthesis of a 
polypeptide chain and its translocation across the ER membrane. 
Indeed, it is this phenomenon which distinguishes protein import 
into the ER lUJ1en from the import of proteins into mitochondria and 
chloroplasts in which translocation of nascent polypeptides has been 
shown to be a post-translational event (Dobberstein et al., 1977; 
Naccechini et al., 1979). Subsequently it has been shown that in 
bacteria (Koshland and Botstein, 1982) and for some proteins of 
yeast (Hansen et al., 1986) translocation is not coupled to 
translation. Recently, Perara et al. (1986) have succeeded in 
uncoupling translocation from translation by using genetically 
engineered mRNAs devoid of termination codons. They have found that 
translocation does not occur spontaneously, a result also observed 
by/ 
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by Connolly and Gilmore (1986). and that translocation may require 
energy expenditure independent of protein synthesis. 
The general mechanism described above can be modified to take 
into account the known complex topologies of different types of 
intrinsic membrane proteins (reviewed by Sabatini et al .• 1982). 
Here. the concept of halt or stop-transfer signals is introduced. 
Proteins that span the lipid bilayer several times. for example PLP. 
would have several of these internal halt signals located within the 
polypeptide chain. Normal translocation would progress until a halt 
transfer signal was encountered. This hydrophobic sequence would 
anchor itself to the membrane while translation is continuing. When 
a polypeptide segment longer than the approximately 40 amino acids 
that are contained within the ribosome emerges it causes the 
ribosome to dislodge from the KR membrane. Translation would 
continue on the free ribosome until an internal signal sequence was 
synthesized then cotranslational insertion of this portion of the 
polypeptide would occur. By a combination of internal uncleaved 
signal sequences and hydrophobic halt-transfer signals the complex 
topology or disposition of the protein about the membrane would be 
constructed. Uncleaved signal sequences have been found in a number 
of intrinsic membrane proteins among them PLP (Colman et al .• 1982) 
and the asialo-glycoprotein receptor (Holland et al .• 1984). An 
examination of several putative halt-transfer signals contained 
within intrinsic membrane proteins has shown that. in addition to 
hydrophobic segments (which presumably span the bilayer). an 
adjacent group of highly charged residues is almost invariably 
present/ 
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present on the carboxyl end of the hydrophobic sequence (Sabatini et 
al., 1982). The charged portion would not penetrate the bilayer and 
so would remain on the cytoplasmic side of the ER membrane. Whether 
ribosome dislodgement would be caused by the high concentration of 
charged amino acids at the site of ribosome-membrane binding or 
siaply by steric hindrance due to the accumulation of nascent 
polypeptide under the ribosome is not known. 
The generation of an intrinsic membrane protein with a 
J1embrane-spanning domain is shown in Figure 18b and much more has to 
be discovered about this process. particularly the crucial 
translocation step. 
(b) Extrinsic "embrane Proteins 
In contrast to intrinsic membrane proteins it had long been 
understood that membrane proteins of the extrinsic or peripheral 
type were synthesized on free polysomes that were distributed 
randomly about the cell cytoplasm. However, our understanding of 
how mRNA is transported within the cell and translated at discrete 
sites has undergone marked changes and considerable evidence has now 
accumulated showing that free polysomes are not simply 'floating• 
around in the cytoplasm but may jn fact be intimately associated 
with the cellular cytoskeleton (Ben Ze'ev et al., 1981; Cervera et 
al., 1981; Ornellas et al., 1986). The cytoskeleton is an 
int.-.cellular structure comprising three major filamentous systems, 
naaely microfilaments (Lazarides, 1976), intermediate filaments 
(Lazarides, 1980) and microtubules (Tucker, 1979). In addition to 
this there are many filament-associated proteins and an irregular 
cytoskeletal/ 
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cytoskeletal structure termed the microtrabecular lattice 
(Wolosewick and Porter. 1979). 
Lenk et al. (1977) developed a fractionation procedure using 
non-ionic detergents whereby the non-extractable residue contained 
the cytoskeletal elements and the soluble fraction consisted of 
soluble proteins. tRNA. monosomes and other material. When examined 
under the Elf it was observed that polysomes were invariably found 
associated with the cytoskeleton fraction. EK studies by Wolosewick 
and Porter (1976) had previously shown polysome clustering in the 
vicinity of the cytoskeleton in intact human diploid cells. Whilst 
the existence of polysome-cytoskeleton associations is unequivocal 
numerous reports have been published which suggest that the 
association is non-random. Polysomes in 3T3 cells are 
preferentially located in perinuclear regions (Fulton et al .• 1980) 
and a discrete distribution of actin. tubulin and vimentin mRNA has 
been described in fibroblasts and myoblasts (Singer and Ward. 1982; 
Lawrence and Singer. 1986). In Xenopus oocytes a differential 
localization for actin. histone (Jeffrey. 1984) and Vgl mRNA 
(Kelton. 1987) has been observed. This spatial segregation of mRNAs 
indirectly suggests that polysome attachment to the cytoskeleton is 
via llRHA binding to the cytoskeleton. Direct evidence for this has 
come from Lenk et al. (1977) who have shown that ribonuclease 
treatment of the cytoskeleton results in the release of ribosomes 
and IIRNA whereas treatment or the cytoskeleton with fluoride (Lenk 
et al .• 1977) and pactamycin (Lenk and Penman. 1979) 1 agents which 
cause ribosome-mRNA dissociation. results in the loss of ribosomes 
but/ 
but not raRNA from the cytoskeletal fraction. 
Evidence that polysomes associated with the cytoskeleton are 
actively involved in protein synthesis has come from several 
studies. The initiation factors eIF-2, eIF-3, eIF-4A and eIF-48 
(Howe and Hershey, 1984) and an aminoacyl-tRNA synthetase complex 
(Kirande et al., 1985) are preferentially associated with the 
cytosk.eleton and it has also been shown that translation only 
functions when aRNA is bound to the cytoskeleton (Cervera et al., 
1981; Koon et al., 1983; Ornelles et al., 1986). When the 
cytosk.eleton is disrupted by the microfilament-specific drug 
cytochalasin D and IIRNA is released into the soluble fraction 
protein synthesis in the cell was inhibited in direct proportion to 
the amount of mRNA released. In vitro studies have shown that the 
translational capability of mRNA released into the cytoplasm from 
cytochalasin treatment of HeLa cells is unaltered but the same mRNA 
is not translated in cytochalasin-treated intact HeLa cells 
(Ornelles et al., 1986). 
In a study using several eutaryotic viral and cellular mRNAs 
Bonneau et al. (1985) were able to demonstrate that all the mRNAs 
associated with the cytosteleton during protein synthesis 
irrespective of their 5' and 3' termini structure. The same report 
also argues that the association of mRNA with the cytoskeleton is 
required but is not sufficient for eutaryotic protein synthesis 
since infection of African green monkey cells by vesicular 
stoaatitis virus inhibited actin synthesis but did not cause the 
release of actin aRNA fro• the cytosteleton. In addition, the same 
group have found that upon suspension of anchorage-dependent cells 
aRNAs/ 
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mRNAs are not released from the cytoskeleton although protein 
synthesis is greatly reduced. Brodeur and Jeffrey (1987) have 
provided recent evidence to support this view. On comparing the 
distribution of cyclohextmide-induced polysome-mRNA accumulation in 
the cytoskeletal and soluble fractions of translationally active 
plasmodia and translationally dormant sclerotia of the slime mould 
Physarium polycephalum they found that translational suppression in 
the sclerotia was not caused by alterations in the sclerotial 
cytoskeleton during starvation since most of the polysomes were 
recovered with the cytoskeleton. In contrast. most of the 
plasmodial cyclohexamide-induced polysomes accumulated in the 
soluble fraction indicating that polysome formation is not dependent 
on a prior association of mRHA or ribosomes with the cytoskeleton 
and also that the cytoskoleton has a limited capacity for binding 
translational components. Taken together. these results indicate 
that protein synthesis does not require an association of polysomes 
with the cytoskeleton and is hence not involved in translational 
control. 
The situation regarding the involvement of the cytoskeleton in 
euk.aryotic protein synthesis will not be resolved fully until 
characterisation of the elements of the cytoskeleton involved in 
mRNA binding is attained. The development of!.!!. vitro systems in 
which the interaction between cytoskeletal and translational 
components can be studied will be of paramount importance in this 
area. Nevertheless. in terms of membrane protein biosynthesis, an 
involvement of the cytoskeleton in ensuring the synthesis of 
specific proteins at discreet sites within the cell's cytoplasm 
close/ 
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close to their ultimate destination appears to be a rational 
hypothesis. 
ii. Kyelin Protein Synthesis 
(a) In vitro 
Studies involving in vitro methods have been carried out over 
the past ten years to determine the sites of synthesis of some of 
the major CNS myelin proteins. Kost of the research to date has 
concentrated on the KBPs and all the evidence shows that these 
proteins are synthesized on free polysomes. 
Early wort by Campagnoni et al. (1978) had demonstrated the 
synthesis of ftBPs by brain homogenates. Subsequent studies by the 
same group (Campagnoni et al .• 1980; Kathees and Campagnoni, 1980) 
examined the ability of several subcellular fractions from mouse 
brain to synthesize KBP. Only the whole homogenate, postnuclear, 
postmitochondrial and postmicrosomal supernatants and free polysornes 
were able to synthesize ftBPs. These results tended to rule out the 
possibility that ftBPs were synthesized on membrane-bound polysomes. 
In these experiments the newly synthesized KBPs were identified by 
their comigration with authentic ftBPs on carboxy-methyl cellulose, 
acid urea gels and SOS-PAGE. A major criticism of these detection 
methods is that they were unable to identify both the pre-large and 
pre-small ftBPs. essential if a precursor-product relationship 
existed between the four KBPs of rodents. A much clearer picture 
emerged when Yu and Campagnoni (1982). using a similar experimental 
approach as before. identified newly synthesized KBPs with an 
antibody which recognized all four forms of mouse ftBPs and concluded 
that there was no evidence for a precursor-product relationship 
between/ 
between the four protein species. The definitive work on the site 
of synthesis of MBPs has come from Colman et al. (1982). Here the 
investigators isolated rat brain mRNA from free and bound polysomes 
and used it to progr&11111e a wheatgerm translation system. 
Innuneprecipitation of KBPs clearly showed that MBPs were 
synthesized on free polysomes and were not synthesized as 
precursors. Like Yu and Campagnoni (1982) they also could find no 
evidence for a precursor-product relationship. Of considerable 
interest was the finding by Colman et al. (1982) that a mRNA 
fraction isolated from myelin-associated polysomes is considerably 
enriched in mRNAs coding for MBPs. This led the authors to suggest 
that the segregation of free polysomes engaged in the synthesis of 
MBPs within myelinating processes serves to ensure that these 
proteins specifically associate with their target membrane ie. 
myelin rather than with other intracellular membranes. 
Two groups (Townsend and Benjamins, 1979; Colman et al., 
1982), utilizing.!.!!. vitro translation methods, have shown that PLP 
is synthesized on bound polysomes as might be expected since it is 
an intrinsic membrane protein (Section 1.4 la). PLP is not 
synthesized as a precursor since the primary translation product is 
indistinguishable in electrophoretic mobility from the mature 
protein (Colman et al., 1982); these authors also showed a 
requirement for SRP in order to ensure efficient insertion into the 
RER membrane during synthesis. 
The types of study described above not only determine the site 
of synthesis of a particular protein but are of use in elucidating 
precursor-product relationships and possible developmental controls 
of/ 
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of transcription and/or translation. 
(b) In vivo 
The kinetics of incorporation of newly synthesized myelin 
proteins into the growing myelin membrane has provided information 
on the routes of protein traffic in the oligodendrocyte. Two of the 
earliest studies to examine the entry of newly synthesized proteins 
into myelin were those of D'Monte et al. (1971) and Smith and 
Hasinoff (1971). Both groups concluded that the high molecular 
weight proteins entered myelin first followed by MBPs and finally 
PLP. However, these experiments were carried out on rats of 40-50 
days old and the rate of myelination is greatly decreased at this 
age. A subsequent study using intracranial injection of a 
radiolabelled amino acid into young rats (Benjamins et al., 1975) 
showed that newly synthesized CNPase and MBPs reached maximal 
specific radioactivity after 2 hours and remained constant for 24 
hours. PLP, on the other hand, was observed to accumulate 
radioactivity for 6 hours then leveled off. This indicated a delay 
in the appearance of PLP in myelin relative to CNPase and MBPs. 
Short time point experiments have shown conclusively that newly 
synthesized KBPs (Colman et al., 1982) and CNPase (Benjamins et al .• 
1978) were incorporated rapidly into the growing myelin membrane 
indicating little delay between their synthesis and appearance in 
myelin. Both groups also observed a delay of at least 30 minutes 
until newly synthesized PLP was incorporated into myelin and Colman 
et al. (1982) detected labelled PLP in brain microsomal fractions as 
little as 2 minutes after injection. These results, particularly 
those of Colman et al . (1982) are consistent with a mechanism 
whereby/ 
whereby PLP is synthesized at the RER and is subsequently 
transported through the Golgi apparatus and from there to the plasma 
membrane. This has been supported by Townsend and Benjamins (1983) 
who used monensin to disrupt Golgi-derived vesicle transport. Under 
these conditions the entry of PLP into myelin was inhibited by 40~ 
but little effect on the entry of the ftBPs was observed. 
Karin and Waehneldt (1985) have suggested that CNPase is 
synthesized on free polysomes since the labelled protein was found 
to accumulate in rat optic myelin rapidly after synthesis and 
monensin had no effect on the appearance of the protein. Of 
interest was the finding that labelled CNPase was also found in a 
microsomal fraction with the same kinetics of incorporation as that 
for myelin. The identity of the membrane(s) involved is unknown 
however the authors suggest that this may serve as a membrane 
intermediate in myelin formation. 
Differences in the kinetics of entry of the major proteins 
into the growing myelin membrane suggests that the formation of the 
membrane is a multistep continuous process rather than a one-step 
discontinuous one. The intrinsic membrane proteins are synthesized 
at the RER and once they become incorporated into the 
oligodendrocyte plasma membran~. at the cell body or in the process 
itself. lateral diffusion may be responsible for delivery of the 
protein to the myelin membrane. Conversely, extrinsic proteins may 
be synthesized throughout the cytoplasm or the oligodendrocyte or in 
discrete areas close to the growing membrane (Colman et al .• 1982) 
although the mechanism responsible for their transport to the myelin 
membrane may be the same as for intrinsic proteins (Benjamins, 
1984)./ 
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1984). "any investigators have tried to isolate membrane fractions 
that may correspond to stages in the transport of myelin proteins 
from their proposed sites of insertion to their ultimate 
destination, the compact myelin sheath. 
Two main approaches have been taken: (1) the isolation of 
myelin-associated membranes in the hope of identifying specific 
membrane populations that may serve as intermediates or precursors 
to the mature membrane; (2) the fractionation. by sucrose gradients. 
of purified CNS myelin. These studies are aimed at identifying 
possible transition membranes. the differences in density reflecting 
different stages of maturation of the myelin sheath. 
Using the first approach Agrawal et al. (1974) found that the 
membranes released from myelin during osmotic shock treatment 
contain myelin constituents and had metabolic properties that 
suggested they were myelin precursors. Further biochemical analysis 
has shown that this membrane fraction is really a heterogenous 
mixture of endoplasmic reticulum (Waehneldt and Kandel. 1972). 
axonal (Haley et al., 1981) and Golgi membranes (Benjamins et al., 
1982). 
Kore information about possible transition of precursor 
membranes to mature compact myelin has come from fractionation of 
the purified myelin membrane itself. In a double isotope labelling 
study. Benjamins et al. (1976) found that PLP appeared first in the 
denser subfractions (composed mainly of vesicular single-membrane 
structures) then later in lighter subfractions corresponding to 
typical multilamellar myelin. In contract. KBPs were observed to 
enter all membrane subfractions simultaneously. The results 
suggested/ 
suggested that the denser subtractions contain pools of PLP and may 
serve as precursors to the lighter subfractions and that MBPs do 
genuinely enter all the membrane fractions simultaneously or move 
very rapidly from the lower 'precursor' subfraction to the lighter 
ones. 
Three studies using young and adult rats (Waehneldt, 1978; 
Waehneldt and Lane, 1980; Lane and Fagg, 1980) have shown that the 
peat position of brain myelin shifts to a denser region of the 
sucrose gradient as the animal matures. Furthermore, several 
developmental trends regarding the abundance of myelin proteins in 
different membrane subfractions were apparent. The lighter membrane 
fractions contained a lower proportion of high molecular weight 
proteins than the heavy fractions, a higher level of MBPs and a 
lower level of CNPase and PLP. Lane and Fagg (1980) also observed 
that the ratio of PLP to MBPs decreased in the heavy myelin 
subfractions of young animals although in older animals where the 
overall rate of myelination has slowed considerably no clear trends 
were apparent and these observations suggest that MBPs are deposited 
in the myelin sheath slightly later than PLP. There is still 
considerable debate about this matter since during myelin 
development this ratio has been shown to increase (Morell et al., 
1972), decrease (Magno-Sumbilla and Campagnoni, 1977), or remain 
unaltered (Adams and Osborne, 1973). 
(c} In Tissue Culture 
Several different culture systems exist for the study of 
myelination. These are explant cultures, dissociated-reaggregated 
cell cultures, dissociated-attached cell cultures, isolated 
oligodendrocytes/ 
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oligodendrocytes and clonal lines (reviewed by Pfeiffer. 1984). The 
first three culture systems consist of a mixture of cell types the 
proportions of each depending on the particular experimental 
approach taken. Clonal lines of oligodendrocytes would appear to 
satisfy all the requirements for studying myelination in an 
environment which is not influenced by other cell types and 
providing optimum conditions for external manipulation. However the 
clonal lines that exist have not as yet realized their full 
potential and while they exhibit some myelin characteristics, for 
example CNPase activity (Sundarraj et al .• 1975) difficulties in 
expressing appreciable levels of KBPs have been encountered. The 
development of methods for the selective enrichment of 
oligodendrocytes (McCarthy and DeVellis. 1980) and their ability to 
produce a myelin-like membrane in culture (Rome et al., 1986) has 
enabled investigators to study the metabolism or these cells in the 
virtual absence or astrocytes and neurons. The developmental 
expression of myelin proteins has been studie4 in cultured 
oligodendrocytes using two different techniques, inununocytochemistry 
using antibodies directed against the proteins themselves and in 
situ hybridization where. by the use of cDNA and/or oligonucleotide 
probes. the location and abundance of a particular mRNA can be 
established. 
Zeller et al. (1985) found that the percentage of KBP mRNA and 
KBP-positive cells peaks at around 15 days postnatal in rat 
oligodendrocytes and decreases thereafter. Furthermore they 
reported that the time of emergence of the KBPs appeared to be 
determined at a very early stage in their development and also bore 
a/ 
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a striking correspondence to the time of KBPs appearance in the 
intact animal. KBP expression was observed in oligodendrocytes 
derived from spinal cord before those from mid-brain or hemispheres, 
a situation that is seen in vivo. Thus it appears that the 
developmental expression of the KBP gene occurs in a similar time 
frane in vitro and in vivo. 
In a detailed study involving KBP, PLP and KAG, Dubois-Dalcq 
et al. (1986) have shown that both KBP and MAG first emerge between 
sand 7 days postnatal followed by PLP 1 to 2 days later. KBP was 
seen to be distributed throughout the cytoplasm whereas KAG was 
observed at perinuclear locations and PLP exhibited a granular 
staining pattern. These workers also found that KAG was detected in 
oligodendrocyte processes much earlier than KBP and PI.P after their 
emergence in the oligodendrocyte cytoplasm suggesting that KAG may 
be transported to the periphery of the cell where it may be needed 
for specific interactions with axons as proposed earlier (Trapp et 
al., 1984). Both Zeller et al. (1985) and Dubois-Dalcq et al. 
(1986) have shown that these events take place in the absence of 
neurons and hence are not dependent on neuronal factors for their 
expression. Bologa et al. (1986) however have provided evidence 
that the production of KBP in cultured oligodendrocytes is regulated 
by a soluble neuronal factor. Support for this observation has come 
from Macklin et al. (1986) who have shown that KBP and PLP RNA 
levels increased fourfold when oligodendrocytes were co-cultured 
with chick spinal cord neurons. Thyroid hormone (T3) has recently 
been shown to increase KBP mRNA levels (Shanker et al., 1987) 
indicating that KBP synthesis regulation by T3 is a 
pre-translational/ 
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pre-translational event. Regulation of mRNA levels by T3 has been 
observed in other systems (Dozin et al., 1985; Gustafson et al., 
1985) however the exact mechanism by which it does this is unknown. 
Levels of CNPase activity have been shown to increase in the 
presence of cAKP (KcRorris, 1983) however it remains to be 
established whether this is due to a general increase in CNPase 
concentration in the oligodendrocytes or an increased amount of a 
specialized CNPase-rich cellular compartment such as a myelin 
precursor membrane. cARP induction of CNPase activity has also been 
shown in c6 glioma cells. In this case the increase in CNPase 
activity is due to an increased number of newly synthesized CNPase 
molecules and not an increase in the catalytic activity of each 
CNPase molecule (RcKorris and Sprinkle, 1982). 
In summary, the use of tissue and cell culture to study the 
very early events of myelinogenesis is still in its infancy. 
However as these culture systems are becoming more established 
substantial gaps in our knowledge of this area will gradually be 
filled. 
1.5 DE1'YELINATION - RULTIPLE SCLEROSIS 
Kultiple sclerosis (RS), first described by Charcot in 1877, 
is by far the connonest of the demyelinating diseases in the Western 
world though its cause remains unknown. From a gross anatomical 
point of view the disease manifests itself as pale areas (plaques) 
of demyeltnation within the white matter of the brain and spinal 
cord. Functional damage is primarily in the spinal cord and results 
in the dysfunction of neurons concerned mainly with limbic function 
and/ 
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and bladder control. Coronal sections through the brains of MS 
victims taken at autopsy reveal multiple disseminated plagues that 
range in size from about Imm to several centimetres (Figure 19). 
Clinical diagnosis of KS is not easy since no specific test for the 
disease exists and diagnosis is usually based on detailed clinical 
history and extensive neurological examination (Traugott and Raine, 
1984). The disease strikes mainly at people in early adulthood, 
predominantly female. and due to the variability of the duration and 
intensity of the disease it is almost impossible to give a prognosis 
regarding individual patients although the mean life expectancy has 
increased to about 35 years due to comprehensive care and the 
availability of antibiotics (Poser et al .• 1982). 
MS is classed as an "acquired autoimmune (inflanunatory) and 
infectious disease of myelin" and the degeneration of the myelin 
sheath resulting in naked axons (Figure 20) is considered secondary 
to the putative infection. It is hypothesized that an autoimmune 
reaction to myelin antigens develops (Raine. 1984b). 
Epidemiological data would seem to support the widely held 
view that the causative agent is viral in nature since high 
instances of the disease are found in temperate latitudes. In 
contrast. MS is almost unheard of in Africa and many parts of Asia. 
In addition to geographic factors. the presence of 
histocompatability (HCA) antigens A3. 87. DW2 and DRW2 appear to be 
significant (Oger et al .• 1980) and might explain the increased 
incidence of KS within the families of diseased patients (Sadovnick 
and MacLeod. 1981). 
Throughout the years many claims of having detected the "KS 
virus"/ 
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I , o . 1 9 . Co1onal slice from a chronic multiple sclerosis 
b1ain. The dc~ycl1natcd plaques are clearly 
v1. i>lc (arrows). From Raine (1984b) 
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virus" have been made, amongst them measles virus (reviewed by 
Iivanainen, 1981), and a 'paramyxoviruslike material' (Prineas, 
1972). Other reports have also suggested that a coronavirus or 
distemper virus might be involved. However to date, no hard 
evidence to back up the virus theory has emerged although some 
circumstantial evidence from a number of conditions related to KS 
suggest that a virus is the likely candidate. 
I11111unological evidence that would indicate abnormality of 
innune regulation at the cellular and humoral level is equally 
inconclusive. Many workers have shown sensitization or blood 
lymphocytes against myelin components in MS (Lisak, 1980; Traugott 
and Raine, 1981) indicating involvement of the cell-mediated immune 
system. At the humoral level antibodies have been detected, in the 
cerebrospinal fluid (CSF) or KS patients, against KBP (Panitch 
al., 1980) and oligodendrocytes (Traugott and Raine, 1981) and 
general the IgG level in the CSF of the majority, but not all, 
patients is elevated. This issue is further complicated by the 
presence of antibodies against myelin components in the sera of 
patients and surrerosof other neurological diseases totally 
unconnected with MS, for example peripheral neuropathy 
et 
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(Brophy, P. J., personal connunication). During demyelination a 
rapid proliferation of astrocytes is observed (gliosis) and Bologa 
et al. (1985) have shown that MBP can stimulate their proliferation 
in vitro. These authors speculate that early attempts to 
innunosuppress MS patients to KBP (Romine and Salk, 1983) were 
unsuccessful due to increased astrocyte proliferation causing 
mechanical obstruction to remyelination. 
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Hope for a cure for KS in the near future appears bleak. 
Charcot (1877) wrote at the time "It is not rare to meet with 
remissions and even with complete intermissions. which give rise to 
hope or a decided cure" and it is the limited ability of the CNS to 
re•yelinate axons which is thought to be responsible for the 
wariability in the prognosis of the disease. Remyelination of the 
CNS by injecting Schwann cells into spinal cord lesions of 
experimental animals has been demonstrated by Blakemore (1977) and 
Itoyaaa et al .• (1983) and Harrison and Pollard (1984) have shown 
that these PNS myelin-foraing cells accomplish remyelination in the 
CNS much more frequently than oligodendrocytes. The reasons for 
this are not clear. 
Kore recently Kohsaka et al. (1986) have transplanted purified 
oligodendrocytes into the corpus striatum of Shiverer mice. a 
dysmyelinating mutant lacking KBP. Electron microscopy revealed 
that many axons beca.ne myelinated and stained heavily with antiserum 
against KBP. This study showed that mature oligodendrocytes are 
able to survive and myelinate host axons even in adult brains. 
The administration or purified myelin-forming cells into CNS 
lesions. whilst not curing the problem. may arrest further 
degeneration of the patients facilities and must. therefore. be 
explored further. 
1.6 AIRS OF THIS STUDY 
A major goal of investigators engaged in membrane biosynthesis 
and assembly is to understand the mechanisms whereby proteins are 
synthesized. sorted and transported to specific sites on their 
target/ 
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target 11e11branes. The myelin menbrane provides an excellent model 
for studying these problems due to its relatively simple protein 
c011position and the high degree of purity with which it can be 
obtained in abundance. 
The ain of the project was to establish the sites of 
biosynthesis of major CNS myelin proteins and to follow their 
incorporation into the growing myelin membrane. Furthermore, it was 
of considerable interest to determine if myelin-associated RNAs were 
enriched in messages encoding these proteins, as is the case for the 
KBPs (Colman et al., 1982). The involvement. if any, of the 
cytosteleton in myelination was also to be investigated with a view 
to establishing a potential role for this structure in the assembly 
process. 
,~ 
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Materials and Methods 
2.1 BULK IIYELIN ISOLATION 
Advantage is taken of myelin's characteristically low buoyant 
density in order to isolate myelin essentially free of contaminating 
membranes. 
The procedure is a modification of Norton and Poduslo 
(1973a). Wistar rats (4-6 weeks old) of both sexes from our own 
breeding colony were killed by co2 inhalation and the brains 
quietly removed and frozen in liquid N2 or solid co2 . A S~(w/v) 
homogenate was prepared by homogenizing the brains in ice-cold 0.85K 
sucrose containing l<>mM Hepes, pH7.4, 3mll DTT and lmK TLCK using a 
Potter-Elvehjem glass homogenizer (Orme Scientific, Manchester, 
UK). The homogenate (40ml) was overlayed with 25ml of 0.25K 
sucrose/lOmK Hepes, pH7.4/3mK DTT/lmll TLCK in polycarbonate 
centrifugation tubes and centrifuged at 70,000g for 90 min at 4°c 
in a KSE 3 x 70ml swing out rotor. After centrifugation, crude 
myelin was removed from the 0.25 - 0.8SK sucrose interface and 
subjected to osmotic shocking by resuspending the myelin in 10 vol. 
of ice-cold double distilled H2o containing lmK TLCK. After 
centrifugation (23,000g for 30 min at 4°C, Sorvall SA600 rotor) 
the supernatant, containing contaminating microsomes, was discarded 
and the myelin pellet subjected to a further 2 rounds of osmotic 
shocking centrifuging at 17,000g on the final shock. 
The purified myelin pellet was resuspended in a small volume 
of double distilled H20, aliquoted and stored at -20°c. 
Kyelin was also isolated from other tissue sources using this 
same general method. 
2.2/ 
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2.2 SUBCELLULAR FRACTIONATION AND RNA KXTRACTION 
In all experiments involving RNA it is extremely important to 
exclude ribonuclease activity and sterile conditions must be 
maintained throughout. 
i. Subcellular Fractionation 
The method used was a modification of Colman et al. (1982). 
The concentration of all sucrose solutions were checked with a 
refractometer. 
Sprague Dawley or Wistar rats of both sexes aged between 13-32 
days old, a time when the rate of CNS myelination is maximal (Banik 
and Smith, 1977), were used in all experiments. 
After decapitation, brains (including brainstem) were removed 
and immediately placed in ice-cold 0.25M sucrose/lOmM Hepes, 
pH7.4/3mM OTT. Each brain was homogenized in this solution (3.Sml) 
using a Potter-Elvehjem glass homogenizer fitted with a PTFE pestle 
and centrifuged at 4,000g for 15 min at 4°C to remove cell debris 
and nuclei. The supernatant was removed and centrifuged again. The 
post-nuclear supernatant was adjusted to l.4M sucrose and this 
solution (9ml) was overlayed onto 1.9M sucrose (1.Sml). The 
discontinuous gradient was completed by layering 0.25M sucrose over 
the l.4ft sucrose solution. All sucrose solutions contained lOmM 
Hepes, pff7.4 and 3mft OTT. After centrifugation at 105,000g for 30h 
at 4°c (MSE 6 x 16.5 swing out rotor) the rough microsomal 
fraction was removed from the 1.4 - l.9M sucrose interface, diluted 
(1:1) with double distilled H2o and centrifuged at 105,000g for 2h 
at 4°c. Free polysomes were recovered in the pellet from the 
sucrose gradient. Myelin for these experiments was obtained by 
scaling/ 
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scaling down the procedure in Section 2.1. 
ii. Electron Microscopy 
Electron micrographs of free polysomes and rough microsornes 
were obtained by a method similar to that of Hubbard et al. (1983). 
Samples were fixed in glutaraldehyde (3~.v/v) in O.SK 
Na2 HP04/NaH2Po4• for lh and centrifuged at 200,000g for 30 
min at 20°c in a KSE 3 1 6.Sml swing out rotor. The pellets were 
washed in the phosphate buffer, post-fixed in 2~{w/v) oso4 and 
stained!!!. bloc with 2~(w/v) uranyl acetate for lh. After staining, 
the samples were dehydrated stepwise in solutions of ethanol, 
centrifuging briefly between steps. until finally they were 
suspended in anhydrous ethanol. The pellets were embedded in ~MlX 
resin (Emscope, London. UK) in propylene oxide and ultra-thin 
sections obtained using a LKB Ultratome III microtome. The sections 
were stained with 0.2~{w/v) lead citrate in O.lK NaOH and 8~(w/v) 
uranyl acetate for 20 min each at room temperature and electron 
micrographs obtained with a JEOL lOOC electron microscope at 80V. 
Electron micrographs of the Triton X-100 {cytoskeletal) pellet 
(Section 2.6 ii) were also obtained using this method. 
iii. RNA Extraction 
In recent years the use of guanidinium salts as potent 
chaotropic agents to dissociate ribonucleo-protein complexes and 
inactivate ribonucleases has proved helpful in the isolation of 
intact, biologically active RNA. 
Depending on the initial sample volume two methods were used 
to isolate total RNA from brain or subcellular fractions. 
(a)/ 
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(a) Guanidine/Caesium Chloride Method {for large tissue 
samples and volumes) 3ml) 
The method takes advantage of the fact that the buoyant 
density of RNA in CsCl is much greater than that of other cellular 
macromolecules. 
The procedure used was a modification of Liu et al. (1979). 
Cellular fractions and brains were homogenized (5~,w/v) at 
room temperature in 6K guanidine HCl (Grade 1, Sigma) containing 
0.4~(v/v) Triton X-100 (BioRad Laboratories, Watford, UK), 25mK 
sodium acetate, pH5.5 and lOmK p-mercaptoethanol using a 
Potter-Elvehjem homogenizer. The homogenate (50ml) was layered over 
a lOml cushion of 5.7K CsCl/lOOmK EDTA, pH6.l, and centrifuged at 
70,000g for 22h at 22°c. The supernatant was discarded and the 
wall of the tube dried carefully while inverted. The crude RNA 
pellet was dissolved in 2ml of double distilled H2o and heated 
gently if necessary. Phenol/chloroform (2ml) (pre-equilibriated 
with O.lM Tris HCl. pff7.4) was added, the sample vortexed and 
centrifuged at 2,000g for 15 min at room temperature. The upper 
(aqueous) phase was then washed twice with chloroform. 
Sodium acetate, pff5. 5 ..n~ cxfcleJ t.-o 0•2.M and the RNA 
precipitated overnight at -20°c with 2.5 vol. of ethanol. 
Precipitated RNA was recovered by centrifugation at 14,000g for 45 
min at o0c {Sorvall, SA600 rotor) and the ethanol precipitation 
repeated. Purified RNA was washed with pre-cooled 80~{v/v) ethanol. 
centrifuged and dried under N2 . 
The RNA pellet was dissolved in a small volume of double 
0 distilled H2o and stored at -20 c. 
For/ 
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For quantitating the amount of RNA the optical density at 
260nm and 280nm was measured. An 00260 of 1 corresponds to a 
concentration of 30fglml for RNA. The 00260100280 ratio 
provides an estimate of the purity of the RNA, a pure preparation 
having a ratio of 2.0. 
(b) Guanidine/Lithium Chloride Method (for small volume 
samples up to 3ml) 
The combined use of guanidine and LiCl results in the 
precipitation of RNA species which are largely free of DNA 
fragments, polysaccharides and protein. The method used was that of 
Cathala et al. (1983) with modifications. 
Lysis buffer (Sft guanidine HCl/lOmft EDTA/50mK Tris HCl, 
pff7.4/B~{v/v) ~-mercaptoethanol) was added to samples at a ratio of 
7ml buffer per ml or gram of sample, homogenized as for the CsCl 
method and 7 vol. of 4ft LiCl added. The sample was well mixed and 
the RNA allowed to precipitate overnight at 4°C. After 
centrifugation at 14,000g for 90 min at 4°C (Sorvall, SA600 rotor) 
the supernatant was discarded and the pellet resuspended in lml of 
2K LiCl/4M urea. The sample was re-centrifuged as before but for lh 
and the crude RNA pellet dissolved by gentle heating and sonication 
(2 x !Os) in lml of O.l~(w/v) SDS/lmK EDTA/lOmM Tris HCl, pff7.4. 
Purification of RNA by phenol/chloroform and ethanol precipitation 
was carried out exactly as described in Section 2.2 iii (a). 
iv. Poly(A)RNA Isolation 
The existence of poly(A) tails at the 3'-end of most eukaryotic 
mRNAs {Lim and Canellakis, 1970; Darnell et al., 1971) enables one 
to purify this RNA species via hybridization to oligo (dT) or poly{U) 
supports. 
(a)/ 
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(a) Oligo (dT)-Cellulose Chromatography 
t The poly(A) RNA fraction from total brain RNA was prepared 
by the method of Aviv and Leder (1972). Oligo {dT)-cellulose Type 1 
(O.Sg, equivalent to 20mg oligo (dT), Pharmacia) was washed 
successively with 10 vol. each of O.lM NaOH, double distilled tt
2
o 
and O.SK NaCl/0.l~(w/v) SDS/lOmK Tris HCl, pH7.4 (NaCl buffer). Rat 
brain total RNA (lmg in lml NaCl buffer) was heated at 6S 0c for s 
min. cooled on ice and applied to the column followed by 3 x lml of 
NaCl buffer. The run-through was re-applied to the column three 
times and poly(A)+RNA eluted with 4 x lml of double distilled 
H20. The fractions were pooled and ethanol precipitated as 
described in Section 2.2 iii (a). The column was washed with 10 
vol. of lM NaCl containing O.OS~(w/v) NaN3 and stored at 4°c in 
this solution. 
The average yield of poly(A)+RNA was 12~ of the total RNA. 
(b) Poly(U) Affinity Paper 
Rat brain total RNA (200pg in a volume not greater than lOOpl) 
was heated at 65°c for 5 min, chilled on ice and NaCl od.d€c\. t.o 
O•SM. A 2cm2 piece of Hybond mAP (Amersham) was cut out using a 
sterile scalpel blade. placed on several layers of 3MK paper 
(Whatman) and 40Vl of O.SK NaCl/lmK EDTA/20mK Tris HCl. pH7.4 
spotted on carefully. The paper was allowed to dry in air then 
transferred to a sterile petri dish and the RNA sample spotted on 
slowly and left for 5 min. The paper was washed twice for 5 min 
each in Sml of O.SM NaCl/lmlf EDTA/20mK Tris HCl. pH7.4 then twice 
for 2 min each in lOml of 7~(v/v) ethanol and allowed to dry in 
air. The paper was sliced into 4 pieces. transferred to a microfuge 
tube/ 
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tube and lOOpl double distilled H2o added. The sample was heated 
at 10°c for 5 min, vortexed and the strips removed from the liquid 
and trapped by the tube cap. Excess liquid was spun out of the 
paper (3,000g for 5 min, MSE microcentaur) and the poly(A)+RNA 
ethanol precipitated (Section 2.2 iii (a)). The average yield of 
poly(A)+RNA using this method was 101. of the total RNA. 
2.3 IN VIVO LABELLING 
The method used was similar to that of Colman et al. (1982). 
Sprague Dawley or Wistar rats aged between 18-20 days old were 
anaesthetised under ether and injected, via the cerebellum, with 
2.4mCi of c35sJ methionine (specific radioactivity 1,000 Ci/mmol, 
New England Nuclear), allowed to recover, then killed by 
decapitation a_t various time intervals. Subcel lular fractionation 
was carried out (Section 2.2 i) except that 0.85M sucrose/lOmK 
Hepes, pH7.4/3mPI OTT (lml) was included in the discontinuous 
gradient. All sucrose solutions contained 100 units/ml of Aprotinin 
(Sigma) to inhibit proteolysis. Kyelin was collected from the 0.85 
- 0.25K sucrose interface, subjected to osmotic shock and further 
purified on a 0.85M - 0.25K sucrose discontinuous gradient. All 
0 fractions were stored at -20 C. 
2.4 POLYACRYLAIIIDE GEL ELECTROPHORESIS AND WESTERN BLOTTING 
i. Sodium Dodecyl Sulphate - Polyacrylamide Gel 
Electrophoresis (SOS-PAGE) 
Protein samples were routinely analysed in 5-15~ gradient slab 
gels using the discontinuous system of Maizel (1971) as modified by 
Kreibich and Sabatini (1974). Samples (30pg protein per lane) were 
prepared/ 
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prepared by boiling for 2.5 min in a sample buffer containing 
2.5~(w/v) SOS and 125mM DTT. Electrophoresis was carried out at 4mA 
until the sample had entered the stacking gel then increased to 
30mA. Protein bands were visualized by staining for at least 30 min 
in 0.2~(w/v) Coomassie Blue (BDH) in 50~(v/v) methanol and 
destaining in 25~(v/v) methanol/lO~(v/v) glacial acetic acid. 
ii. Two-dimensional PAGE 
The method used was a modification (Althaus et al., 1983) of 
O'Farrell (1975). 
Myelin proteins (SOpg) were resolved by non-equilibrium 
isoelectric focusing in the first dimension in gels of llcm x 4nun 
(internal diameter) containing 2~(v/v) ampholines of pH 2-11 (LKB) 
for 3h and separated in the second dimension by SOS-PAGE in 5-15~ 
gradient slab gels. 
iii. Silver Staining 
Polyacrylamide gels were silver stained for protein in clean 
glass containers by the method of Ansorge (1985) as detailed below. 
1. SO'l.(v/v) methanol/20~(w/v) TCA/2~(w/v) 
2. 
3. 
4. 
s. 
6. 
7. 
8. 
CuC1 2 
lO'l.(v/v) ethanol/S~(v/v) acetic acid 
O.Ol~(w/v) KKn04 
10,.(v/v) ethanol/S~(v/v) acetic acid 
lO'l.(v/v) ethanol 
Double distilled H2o 
O.l~(w/v) AgN03 
10,.(w/v) K2co3 
(20 min) 
(10 min) 
(10 min) 
(10 min) 
(10 min) 
(10 min) 
(10 min in the dark) 
( 1 min in the dark) 
Gels were rinsed briefly in double distilled u2o between 
steps. 
The/ 
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The silver stain was developed in 0.01~ (v/v) formaldehyde/ 
2~(w/v) K2co3 in the dark (usually 5-10 min) and stopped by 
briefly washing in l~(v/v) ethanol/S~(v/v) acetic acid. Stained 
gels were stored in double distilled H2o. 
iv. Western Blotting 
(a} Electrophoretic Transfer 
After SOS-PAGE, proteins were electrophoretically transferred 
to nitrocellulose paper (0.45)1ffl, (Schleicher and Schuell, Anderman 
Ltd) at 0.25A for 6h in a TransBlot apparatus (BioRad Laboratories) 
by the method of Towbin et al. (1979). After transfer, strips were 
sliced off and stained in O.l~(w/v) Amido black, destained using 
PAGE destain and finally immersed in double distilled H2o. The 
remainder of the blot was blocked overnight in PBS containing 
0.2~(w/v) gelatin and O.l~(v/v) Triton X-100 (Buffer I) to quench 
non-specific binding of protein. Stained and blocked blots were 
dried on 3Klf paper and stored at room temperature. 
(b) Irnmunoblotting 
Nitrocellulose blots were incubated in Buffer I containing the 
appropriate dilution of primary antibody for lh at room 
temperature. Blots were washed four times for 5 min each in Buffer 
I minus antibody then incubated in Buffer I containing either goat 
anti-rabbit IgG (Northeast Biomedical Laboratories) (1:1000 or 
1:2000 dilution) or sheep anti-mouse IgG (Scottish Antibody 
Production Unit) at 1:500. Both second antibodies were conjugated 
to horseradish peroxidase. After lh incubation at room temperature 
in the dart. the blots were washed three times for 5 min each in 
Buffer II (PBS/0.l~(v/v) Triton X-100) and finally in PBS. 
Irnmunostaining/ 
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Innunontaining was visualized by the addition of DAB (Sigma) 
(SOmg/lOOml) in SOmK Tris HCl, pH7.4 followed by 30~(v/v) hydrogen 
peroxide (10~1 per lOml of DAB solution). The reaction was stopped 
by rinsing the blots in 2~(w/v) SOS and inununoblots were stored at 
room temperature in the dark. 
(c) CNPase Activity Staining 
Nitrocellulose blots of CNS myelin proteins were stained for 
CNPase activity exactly as described by Bradbury and Thompson (1984). 
2.5 AFFINITY PURlFICATION OF CNPase AND PLP .ANTIBODIES 
i. Purification and Electroelution of CNPase 
Rat brain CNPase was resolved by SOS-PAGE and the protein 
eluted from the gels pieces as described by Hunkapiller et al. 
(1984). Eluted material was precipitated by adding 10 vol. of 
acidified acetone. 
CNPase antiserum was obtained from adult New Zealand White 
rabbits by the method of Colman et al. (1982). Blood taken from the 
0 ear vein was allowed to clot overnight at 4 C and, once the clot 
had retracted, it was centrifuged at 14,000g for 20 min at 4°c 
(Sorvall, SA600 rotor). The serum was decanted and serial dilutions 
tested in innunoblots of rat CNS myelin proteins. 
ii. Affinity Chromatography 
Sepharose 48 (Sml, Pharmacia) was thoroughly washed with 10 
vol. of O.SM NaCl and 10 vol. of double distilled H2o. The resin 
was activated using cyanogen bromide according to the procedure of 
March et al. (1974). Excess liquid was removed by filtration and 
the activated resin washed with 10 vol. each of O.lK NaHco
3
, 
pff9.S,/ 
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pff9.5, double distilled H2o and O.lK Na2co3/0.5M NaCl, pff8.35 
(coupling buffer) and finally transferred to a small glass column 
(BioRad). Triton X-100 (2~.v/v) was added to the purified CNPase 
solution (3.2mg protein) and coupling was carried out using an end 
over end mixer for 12h at 4°C in the presence of 2 vol. of 
coupling buffer. After coupling, the column was washed with 10 vol. 
of coupling buffer and excess reactive sites blocked by incubating 
the resin in 2 vol. of O.lK glycine, pff8.0 for 2h at room 
temperature. The column was washed successively with 10 vol. each 
of O.lK sodium acetate/0.5K NaCl. pH4.5, O.lM Tris borate/0.5 
NaCl/0.5~(v/v) Triton X-100, pH8.S, PBS/0.l~(v/v) Triton X-100/2mK 
EDTA, pH7.4 and finally PBS, pff7.4. CNPase antiserum (4ml) 
containing O.SM NaCl, O.l~(v/v) Triton X-100, 2mK EDTA and lOmK 
Hepes, pH7.4 was centrifuged at 14,000g for 30 min at 4°c and the 
supernatant injected onto the column through a 0.22p.m sterile filter 
(Flow Laboratories). Incubation was carried out for 2h at room 
temperature and the column was washed with PBS, pff7.4 until the 
optical density at 280nm of the eluent was less than 0.03. CNPase 
antibodies were eluted with O.lM glycine/0.15M NaCl, pff3.0 and lml 
fractions were collected into O.Sml of O.SM NaH2Po4, pff8.0. An 
00280 elution profile was obtained and relevant fractions pooled, 
dialysed against 51 of PBS, pff7.4 for 3h at 4°C, concentrated in a 
freeze dryer, aliquoted and stored at -10°c. 
iii. PLP 
PLP antiserum (330pl) {from Dr E Blair, Department of 
Biochemistry, University of Leeds) was affinity purified using a lml 
{approximately lmg of PLP) affinity column scaling down the 
procedure/ 
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procedure already described. This antiserum also contained 
antibodies versus MBP. These were removed using an appropriate 
affinity column. 
2.6 CYTOSKELETAL EXTRACTIONS 
i. Single-cell Suspensions 
Wistar rats of both sexes aged between 15-19 days old were 
killed by co2 inhalation and the brains quickly removed and placed 
in Hanks Balanced Salt Solution (with NaHC03 and without ca
2
+ 
and Mg2+, Flow Laboratories) at room temperature. A single-cell 
suspension was prepared by coarsely chopping the tissue and forcing 
it through one layer of 136pm Nybolt (Plastok) then twice through 
one layer of 30pm Nybolt. The cells were harvested by 
centrifugation at l,OOOg for 3 min at room temperature (KSE Kultex) 
and gently resuspended in CSK buffer minus Triton X-100 (6ml per 
brain; see Table 2 for the buffer composition). After 
centrifugation as before, the cells were gently resuspended in CSK 
buffer (6ml per brain), lysed at 30°c for 1 min with gentle 
shaking and centrifuged at 14,000g for 5 min at 30°c (Sorvall, 
SA600 rotor). The supernatant (soluble fraction) was carefully 
removed and the pellet washed in an equivalent volume of CSK buffer 
(without Triton X-100) and centrifuged as before. 
The supernatant was retained (wash fraction) and the 
cytoskeletal pellet resuspended in a volume of CSK buffer equal to 
that of the soluble fraction. This fraction was designated the 
cytoskeleton fraction. For protein distribution analysis, aliquots 
of each fraction were electrophoresed and immunoblotted (Section 
2.4). 
For/ 
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TABLE 2 CONSTITUENTS OF THE CSK BUFFER 
Stock. Solution 
lOOmM Pipes, pff6.8 
501.(v/v) glycerol 
101.(v/v) Triton X-100 
300mM ftgC1 2 
lOOmM EGTA 
llf KCl 
l<>mM Taxol 
50mft TLCK 
lmg/ml Leupeptin 
lmg/ml Antipain 
2mll Pepstatin A 
llf Benzamidine 
Final Concentration 
lOmK 
201.(v/v) 
0.51.(v/v) 
lmll 
2mK 
lOOmll 
50)1K 
lmK 
lOpg/ml 
lOJlglml 
15pM 
lOmM 
The pH was adjusted to 6.8 and the solution filtered through a 
0.2pm sterile filter. 
Leupeptin, Antipain and Pepstatin A were obtained from Peptide 
Institute, Osaka, Japan and Taxol from NIH, Bethesda, USA. 
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For RKA extraction the cytoskeletal pellet was further 
extracted by a modification of Bird and Sells (1986). The pellet 
was homogenized at 4°C using a Potter-Elvehjem homogenizer in 6ml 
CSI buffer containing 0.25K (NH4)2so4 but without KCI and 
incubated on ice for 10 min. After centrifugation at 10.ooog for 20 
min at 4°C (Sorvall. SA600 rotor) the supernatant was retained as 
the purified cytosteleton. The pellet contained mainly nuclei, 
insoluble cell debris and heterogenous nuclear RNA. RNA was 
extracted from both soluble and purified cytoskeletal fractions 
(Section 2.2 iii) and the CSI buffer contained 5 units/ml Human 
Placental Ribonuclease Inhibitor (HPRI) (Amersham). 
ii. Kyelin-associated Cytoskeleton 
Rat brain myelin was resuspended in CSK buffer (lmg/ml) and 
incubated for 10 min at 30°c. After centrifugation (13.400g for S 
min at room temperature. KSE microcentaur) the supernatant was 
retained (soluble fraction) and the pellet extracted again. The 
final pellet was resuspended in CSK buffer to a volume equivalent to 
that of the soluble fraction. 
iii. Lipid Analysis 
Rat brain myelin (2mg) and the cytoskeletal pellet from lOmg 
of rat brain myelin (Section 2.6 ii) were made to lml total volume 
and centrifuged cso.ooog for 20h at 4°c. KSE 6 x 16.5 swing out 
rotor) through a continuous 0.3-l.2K sucrose gradient. Fractions 
(O.Sml) were collected and SOpl of each were solubilized in 2~(w/v) 
SOS at so0 c for 15 min. cooled and the 00280 obtained. A 
further SOpl from each fraction was analysed by SOS-PAGE (Section 
2.4 i). 
Lipid/ 
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Lipid was extracted from the remainder of each fraction by the 
method of Bligh and Dyer (1959). Dried samples were dissolved in 
20pl of chloroform/methanol (1:1,v/v) and spotted onto activated 
(100°c for lh) Kieselgel 60 (Merck) TLC plates. After resolving 
the lipids in methyl acetate/isopropanol/chloroform/methanol/ 
0.25~{w/v) KCl (25:25:25:10:9 by volume; Burgisser et al., 1986) the 
plates were dried in air and the lipids stained lightly with iodine 
vapour. 
For quantitative purposes total lipid extracts from either 
whole myelin or the cytoskeletal pellet were analysed for 
phospholipid (Eng and Noble, 1968), sulphatides (Kean, 1968), 
cerebrosides (Kacala et al., 1983) and cholesterol (Sperry and 
Brand, 1943). Individual phospholipids were quantitated by scraping 
the relevant spots off the TLC plate and subjecting them to 
phosphate analysis as for the total phospholipids. 
2.7 CELL-FREE TRANSLATIONS 
i. Wheatgerm Extract (WGE) Preparation 
It is extremely important to maintain sterile conditions 
throughout the entire preparation. 
G25 (medium) Sephadex (Pharmacia) was pre-swollen in 20mM 
Hepes, pff7.4/50mlf KCl/lmK KgC12 and autoclaved. DTT was added to 
2mK and a glass column packed to a bed volume of 160ml. Wheatgerm 
(3.9g) (Robert Hutcheson's Kills, Kirkcaldy) was ground in liquid 
N2 using a pre-cooled mortar and pestle. After the N2 had 
evaporated the ground wheatgerm was added to lOml of extraction 
medium (111111 Kg acetate/90mK KCl/2mK OTT) and centrifuged at 12,000g 
for/ 
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ror 12 min at 4 C (Sorvall. SA600 rotor). The supernatant was 
decanted from under the lipid layer using a pasteur pipette and made 
to 20mlf Hepes. pH7.4 and 2mft Mg acetate. The sample was centrifuged 
as before and the supernatant layered onto the Sephadex column. The 
flow rate was adjusted to 75ml/l and. after discarding the front 
{1-1. Sml). lOml of the turbid fraction of the void volume were 
collected. aliquoted. frozen in liquid N2 and 0 stored at -70 C. 
ii. Optimization or the System 
The ionic optima for translation in the WGE system must be 
determined for the particular RNA added. Depending on the set of 
+ 2+ 
experiments the K and Kg optima were determined using either 
total RNA or poly(A)+RNA (4 OD Units/ml) in a translation mix that 
contained 20-120mlf K acetate. 0.6-41111' Mg acetate. 4pl of Kastermix 
(see Table 3). 30-60pCi (35sJ methionine (specific radioactivity 
1000 Ci/mmol. Amersham). lmft TLCK. 200 units/ml HPRI and lOpl WGE in 
a total volume of 25pl (including RNA). Translation was initiated 
by the addition of RNA and incubation carried out for 90 min at 
26°c. The amount of RNA used in each translation was also 
optimized using optimal K+ and Mg2+ concentrations. 
Incorporation of radioactivity was determined by spotting 2.Spl 
aliquots from each translation onto 3Kft paper filter discs (2.lcm 
diameter, Whatman) and precipitation by TCA as outlined below: 
Ice-cold 10,.(w/v) TCA (10 min) 
Ice-cold S~(w/v) TCA (5 min) 
Boiling S~(w/v) TCA (15 min) 
S~(w/v) TCA (5 min) 
Ethanol (5 min) 
l:l(v/v)/ 
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TABLE 3 CONSTITUENTS OF THE WGE TRANSLATION MASTERMIX 
Concentration in 
Solution Volume (111) , Translation 
Double distilled "20 150 
lmft amino acids (-met) 40 20pK 
lK Hepes, pH7.6 40 20mK 
lOOmft OTT 4 0.2mK 
lOmft Spermine 16 80pK 
lOOmft ATP 20 lmK 
12mft GIP 20 120pK 
800mft Creatine phosphate 20 8mK 
30mg/ml Creatine phosphokinase 8 0.12mg/ml 
All additions were made on ice and after mixing, the Kastermix 
was aliquoted and stored at -10°c. Creatine phosphokinase from 
rabbit muscle (EC 2.7.3.2) and creatine phosphate were obtained from 
Boehringer Mannheim. All other reagents were from Sigma and of the 
highest purity available. 
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l:l(v/v) Ethanol/ether (5 min) 
Ether (5 min) 
Discs were dried under a heat lamp (5 min). transferred to 
scintillation vials and Sml Fisofluor 3 (Fisons) added. Samples 
were counted for 1 min in a United Technologies Packard 200 CA 
Liquid Scintillation Counter. 
iii. Membrane-binding Experiments 
(a) Membrane Preparation 
TLCK-treated rat brain myelin (5.4mg/ml) was sonicated heavily 
(3 x Ss) and centrifuged at 13.400g for 5 min at 4°c (RSE 
microcentaur). A 10 00550/ml suspension was prepared by diluting 
with double distilled n2o. Salt extracted membranes (DPM) from 
dog pancreas and signal recognition particle (SRP) were prepared 
exactly as described by Shields and Blobel. (1978). 
(b) Incubations 
Rabbit spinal cord poly(A)+RNA translations of equal 
TCA-precipitable cpm (60pl) containing lpg/ml leupeptin. antipain 
and pepstatin A were incubated in the presence of n2o (control). 
myelin or DPN(2pl of each) for lh at 26°C with occasional 
shaking. Samples were centrifuged at 13.400g for 20min at 4°c 
(RSE microcentaur) and the supernatants carefully removed and lpglml 
of proteinase inhibitors added to each. Additionally. 2pl of myelin 
were added to the supernatants from the myelin incubations. 
Membrane pellets were resuspended in SOpl of ice-cold PBS. pH7.4 
containing 2pg/ml of proteinase inhibitors. sonicated lightly (2s) 
and re-centrifuged. The supernatants were discarded and SOpl of WGE 
(diluted 1:1.5 in double distilled H20) added to each. All samples 
were/ 
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were sonicated (2s) and stored at -7o0 c. 
For membrane-binding experiments involving KBPs, CNPase and 
PLP the same general method was used except that rat brain 
poly(A)+RNA was used to progranune the translations and DPM and SRP 
(lpl) were added at the start of the translations. 
2.8 IKKUNOPRECIPITATION 
The method used was a modification of Colman et al. (1982). 
In vitro translations (200pl) and in vivo labelled samples 
(23.7pg protein in 200pl) were boiled for 2.5 min in 2~(w/v) SOS and 
diluted four-fold with Solution A (2.S~(v/v) Triton X-100/lmK 
EDTA/100 Units/ml Aprotinin/SOmK Tris HCl, pff7.4, Goldman and 
Blobel, 1978). After centrifugation (13,400g for 5 min at room 
temperature, MSE microcentaur) to remove insoluble material, the 
supernatants were incubated overnight with constant shaking at 4°c 
with affinity purified antibodies (30pl) or antiserum (lSpl) for 
translations and lOOpl of each for samples labelled in vivo. 
Protein A-agarose (Sigma) suspension (30pl of a 33~(w/v) suspension 
in solution A) was added to each sample and, after 2h constant 
shaking at room temperature, the immune complexes were recovered by 
0 
centrifugation (13,400g for 5 min at 4 C, MSE microcentaur) and 
washed three times with Solution A containing O.l~(w/v) sos and 
finally once with Solution A minus detergents. Immunoprecipitates 
were prepared for SOS-PAGE and eletrophoresed as described (Section 
2.4 i). After staining and destaining, the gels were impregnated 
either with En3Hance (New England Nuclear) or Amplify (Amersham) 
fluorographic reagents according to the manufacturers instructions. 
Gels/ 
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Gels were dried under vacuum (Jh), placed under Kodak X-Omat XAR-5 
or Konica A2 X-ray film in Harmer (London) cassettes containing 
0 Cronex intensifier screens and exposed at -70 C. Films were 
developed using Kodak LX-24 developer diluted 1:18(v/v) and Kodak 
FX-40 fixer at l:4(v/v). 
2.9 PHOSPHORYLATION OF CNPase II 
Phosphorylation of CNPase II was carried out by a modification 
of the method of Bradbury et al. (1984). Rat brain myelin (lmg of 
protein) was suspended in lmM KgC1 2/lmM TLCK/0.0S~(v/v) Triton 
X-100/SOmK Tris HCl, pH7.4 with or without SpK cyclic AMP (Sigma). 
The reaction was started by the addition of 50pK ATP and 80pCi of 
cr-32PJ ATP (specific radioactivity 0.5-3Ci/nunol, Amersham) and 
incubation carried out for 8 min at 37°C. Labelled myelin was 
harvested by centrifugation (14,000g for 15min at 4°C, Sorvall, 
SA600 rotor) and aliquots (20pg protein) processed for SOS-PAGE and 
antoradiography. 
2.10 IODINATION OF KYELIN 
Rat CNS myelin (15pg) was radio-iodinated using 2soyci of 
Bolton and Hunter reagent (N-Succinimidyl 3- (4-hydroxy-s-[125IJ 
iodophenyl) propionate) (specific radio-activity,...;2000 Ci/mmol, 
Amersham) according to the method of Bolton and Hunter (1973). 
2.11 PROTEIN DETERMINATION 
Protein content was routinely carried out by a modification of 
Lowry et al. (1951) and included SOS to solubilize membrane proteins. 
Samples/ 
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Samples (200pl total volume) and 10-120pg bovine serum albumin 
(Fraction V, Sigma) were prepared in duplicate. 250pl of IM 
NaOH/0.25~(w/v) SOS was added and the samples incubated at &o0 c 
for 15 min. 2.5ml of Solution 8 (2~(w/v) Na,K.Tartrate (O.Sml)/1~ 
(w/v)Cuso
4 
(O.Sml) in 50ml of 2~(w/v) Na2 co3 ) was added to 
each tube. mixed and incubated for 15 min at room temperature. 
Finally, 250pl of Folin-Ciocalteu reagent (BDH) freshly diluted 
(1:1) with double distilled H20 was added and the optical density 
at 750nm measured after 45 min. A protein standard curve was 
constructed and the protein content of the samples determined from 
it. 
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Results 
3.1 IDENTIFICATION OF CNPase IN RAT CNS KYELIN 
i. The Protein Profile of Rat CNS Myelin 
Figure 21, lane 1 shows the presence of the four abundant 
proteins KBPs, PLP, CNPase and MAG in purified rat brain myelin. 
The apparent molecular weight of CNPase I was calculated to be 48k.Da 
and that of CNPase II SOk.Da. These are similar to those reported 
previously (Drummond and Dean, 1980; Wells and Sprinkle, 1981). 
Also present are the cytoskeletal proteins actin and tubulin which 
are always observed to copurify with rat CNS myelin during 
isolation. For comparison purposes purified myelin from rat sciatic 
nerve is shown in lane 2 and shows an even simpler protein profile 
than that of CNS myelin, the major PNS integral membrane protein, 
Po, accounting for over 50~ of the total protein composition. 
ii. Characterization of CNPase Antiserum 
The imrnunoblot of the two-dimensional gel shown in Figure 22b 
shows that both polypeptides are recognized by the affinity-purified 
CNPase antibodies. Furthermore, the immunoblot also reveals that no 
other polypeptides in rat CNS myelin cross react with the 
antibodies. Figure 23 (lanes 4 and 5) shows that both polypeptides 
that are recognized by the CNPase antiserum have CNPase activity. 
iii. Phosphorylation of CNPase II 
The pattern of phosphorylation of rat CNS myelin proteins is 
shown in Figure 23. Lanes 2 and 3 show that only two proteins were 
labelled to any great extent. KBPs were phosphorylated in a cyclic 
AMP-independent manner, while inclusion of 5pK cyclic AMP resulted 
in the phosphorylation of a protein of apparent molecular weight 
-SOkDa. Superimposition of the autoradiogram on to the stained and 
dried/ 
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Fig. 21. Electrophoretic mobilities of rat brain (CNS) 
and sciatic (PNS) myelin proteins. 
Samples (30pg protein; lanes 1 and 2) were 
analyzed by SDS-PAGE in a 5-15% slab gel and 
stained with Coomassie blue. Lane 3 shows 
Coomass!e blue stained molecular weight 
markers (myosin, 205kDa; B-galactosidase, 
116kDa; bovine serum albumin, 67k.Da; 
ovalbumin, 43kDa; glyceraldehyde-3-phosphate 
dehydrogenase, 36kDa; carbonic anhydrase, 
30k.Da; tryps!nogen, 24k.Da; soybean trypsin 
inhibitor, 20kDa;cl..-lactalbumin, 14kDa). 
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Fig. 22a. Two-dimensional analysis of rat brain myelin. 
Purified rat brain myelin (50pg protein) was 
subjected to isoelectric focusing in the 
first dimension followed, in the second 
dimension, by SDS-PAGE. The proteins were 
silver stained as described in the Materials 
and Methods Section. CNPase I is indicated 
by the arrow and CNPase II by the arrowhead. 
Fig. 22b. Two-dimensional immunoblot of CNPase I and II. 
Purified rat brain myelin (SOvg protein) was 
subjected to two-dimensional gel electro-
phoresis and the proteins transferred to 
nitrocellulose paper. CNPase I and II were 
detected using affinity purified rabbit 
anti-rat CNPase antibodies at 1:500 dilution 
and goat anti-rabbit IgG (peroxidase 
conjugated) at 1:1000. The proteins were 
visualized using DAB as the chromophore. 
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Fig. 23. Cyclic AMP-dependent phosphorylation of 
CNPase II. 
Rat brain myelin (20pg protein) was 
phosphorylated and subjected to SOS-PAGE. 
Lane 1 shows rat brain myelin stained with 
Coomassie blue and lanes 2 and 3 are 
autoradiograms of myelin phosphorylated in 
the absence or presence of SpM-cyclic AMP 
respectively. Lane 4 is an i11111Unoblot of 
CNPase I and II obtained using the sa11e 
dilutions of primary antiserum and second 
antibody conjugate as described in Figure 
22b. Lane 5 shows rat brain myelin stained 
for CNPase activity. 
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dried gel showed that the phosphorylated SOlc.Da protein 
co-electrophoresed with the upper component of the CNPase doublet. 
In this respect rat brain myelin CNPase II is similar to the 
equivalent rabbit enzyme (Bradbury and Thompson, 1984). 
3.2 BIOSYNTHESIS OF CNPase 
i. Subcellular Fractionation of Rat Brain 
Rat brain was subjected to discontinuous sucrose gradient 
centrifugation and fractions corresponding to the rough microsomes 
(Figure 24) and free polysomes (Figure 25) were collected and a 
small portion of each checked by EK. The rough microsomal fraction 
contains the characteristic ribosome-studded membrane vesicles 
derived from the RER while the free polysomes (recovered in the 
pellet) show no contamination by membranes. The appearance of both 
fractions is similar to that reported by Colman et al. (1982). 
ii. Site of Synthesis of CNPase 
Prior to carrying out actual experiments the wheatgerm 
translation system was routinely optimized for potassium, magnesium 
and RNA concentrations for each source of RNA isolated. The results 
of a typical optimization for total brain poly(A)+RNA are shown in 
Figure 26. For this particular RNA the optimal potassium and 
magnesium concentrations were found to be 60m1' and l.6mK 
respectively while the optimal RNA concentration was observed to be 
4 OD U/ml (equivalent to 120pg RNA/ml of translation mixture). It 
is important to carry out these titration experiments to ensure that 
incorporation of the labelled amino acid is maximal, particularly so 
when dealing with proteins whose relative abundancy is low as is the 
case/ 
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Fig. 24. 
Fig. 25. 
Rough aicrosomes from myelinating rat brain. 
The rough microsomal fraction obtained from 
the l.9/l.4H sucrose interface contained 
ribosome-studded meabrane vesicles derived 
from the R.F.R. Free polysomes that 
contaminate this fraction are indicated by 
arrows. x30,000 magnification. 
Scale bar: 0.5 µm x 30,000 
Free polysomes from myelinating rat brain. 
Subcellular fractions were prepared from the 
brains of 15 day old Wistar rats by the 
procedure described in Materials and 
Methods. The free polysomes, not 
contaminated by membranes, were recovered in 
the pellet. xJ0,000 magnification. 
Scale bar: o.S µm x 30,000 
11 2 
Fig. 26. Typical optimization of the wheatgerm 
translation system. 
Translations were carried out in the presence 
of 4 OD U/ml rat brain RNA and varying 
concentrations of a) magnesium acetate 
(0.6-4mM) orb) potassium acetate (20-120mM) 
and RNA optimization was determined by 
translating varying amounts of c) rat brain 
RNA (0.7-6 OD U/ml) at optimal magnesium and 
potassium concentrations. 
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case with CNPase. 
RNA was extracted from both rat brain and rat brain 
subcellular fractions and translated at optimal efficiency in the 
wheatgerm translation system. CNPase and KBPs were 
immune-precipitated from translations containing identical numbers 
of TCA-precipitable cpm and the relative amounts of the polypeptides 
in translations programmed with total rat brain poly(A)+RNA, free 
polysomal RNA and rough microsomal RNA were compared. CNPase I and 
CNPase II were shown to be synthesized on free polysomes (Figure 27, 
lane 3) and to share the same site of synthesis as KBPs 
(Figure 28). Small amounts of CNPases I and II and KBPs were 
detected in the RER lanes (Figure 27, lane 4 and Figure 28, lane 3 
respectively) which was due to some free polysomal contamination in 
the rough microsomal fraction. Comparison of the size of the 
primary translation products produced by in vitro translation of 
total rat brain poly(A)+RNA and those of the mature CNPase 
polypeptides found in purified 125I-labelled rat brain myelin 
shows that CNPases I and II are not synthesized as precursors which 
are cleaved post-translationally (Figure 27, lanes 1 and 2). This 
is further support for the hypothesis that these polypeptides are 
synthesized on free polysomes. 
iii. Non-Enrichment of CNPase mRNA in Kyelin-Derived RNA 
Colman et al. (1982) found that an RNA fraction could be 
extracted from purified rat brain myelin and that this RNA was 
enriched approximately IO-fold in KBP mRNA, relative to total rat 
brain mRNA. It was therefore of great interest to find out whether 
the message for another myelin protein which is also synthesized on 
free/ 
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Fig. 27. Site of syntehsis of rat CNS CNPase. 
Poly (A)+RNA from total brain (4 OD U/ml of 
translation mixture; lane 2) and total RNA 
from rat brain free polysomes (4 OD U/ml; 
lane 3), rough microsomes (2.7 OD U/ml; lane 
4) and myelin (5.4 OD U/ml; lane 5) were used 
to programme a wheatgerm transl-3tlon system. 
After translation, the samples were 
immune-precipitated (2 x 106 cpm per 
sample) with affinity purified anti-CNPase 
antibodies, electrophoresed and subjected to 
fluorography as described in Materials and 
Methods. The dried gel was exposed to X-ray 
film for 10 days at -70°C. Lane 1 shows an 
autoradiogram of rat brain myelin (Spg) that 
had been iodinated using 125r. 
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Fig. 28. 
Fig. 29. 
Site of synthesis of rat CNS MBPs. 
MBPs were translated, immune-precipitated 
with anti-MBP antibodies and detected by 
autoradiography as described in Figure 27. 
MBPs were translated using poly(A)+RNA from 
total brain (lane 1), total free polysomal 
(lane 2) and rough microsomal (lane 3) RNA. 
The enrichment of MBP mRNAs associated with 
rat brain myelin. 
+ Poly (A) RNA from total brain (4 00 U/ml; 
lane 1) and myelin-associated RNA (5.4 OD 
U/ml; lane 2) were translated and analysed by 
6 immunoprecipitation (2.5 x 10 cpm per 
sample) and autoradiography as described in 
Materials and Methods. After a 7 day 
exposure the fluorogram was placed over the 
dried gel to locate the relevant bands, which 
were excised and counted to determine the 
relative ratios of radioactivity in the total 
brain and myelin RNA MBP immunoprecipitates. 
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free polysomes was also enriched in the myelin RNA fraction. Figure 
27 (lanes 2 and 5) shows that when the CNPase polypeptides were 
immune-precipitated from translations containing the same amounts of 
ICA-precipitable radioactivity. there was no evidence of enrichment 
for CNPase message in the myelin RNA relative to total rat brain RNA 
whereas there was a pronounced enrichment of KBP message 
(Figure 29). The ratio of labelled CNPase synthesized by total 
brain mRNA to that produced from myelin-associated RNA was 1:1.3 as 
determined from the radioactivity contained in each CNPase lane 
(1832cpm and 2346cpm respectively). Kyelin-associated mRNA coding 
for KBPs was enriched 13-fold over that for total brain mRNA 
(93536cpm and 7276cpm respectively). 
iv. Kinetics of Incorporation of Newly-Synthesized CNPase 
into CNS myelin 
A crude PLP antiserum was purified and samples from various 
stages of the purification were tested in immunoblots of rat brain 
myelin (Figure 30). The crude antiserum (lane 1) whilst containing 
PLP antibodies also contained antibodies that recognized a series of 
higher molecular weight proteins (-60-90k.Da) and also several lower 
molecular weight proteins thought to be MBPs. Initial purification 
was carried out by affinity chromatography using column to which 
purified PLP had been covalently bound. This purification step 
removed antibodies recognizing the higher molecular weight proteins 
however. contamination by the presumed KBP antibodies was still 
apparent (lane 2). The fact that these antibodies had bound to the 
PLP column suggested that there was some KBPs that had been purified 
along with PLP. a likely explanation since the pre-large KBP runs 
very/ 
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Fig. 30. Purification of PLP antisenua. 
The crude PLP antiserum was purified as 
outlined in Materials and Methods. Rat brain 
myelin imaunoblots were obtained using the 
PLP antiserum at various stages in the 
purification. Lane 1 shows the crude PLP 
antiserum (diluted 1:200); the same antiserum 
after purification via either a PLP (1:25; 
lane 2) or a HBP (1:5; lane 3) affinity 
column. Lane 4 shows the positions of the 
HBPs when the same blot was 1.maunostained 
using MBP antiserum (l:1000). 
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Fig. 31. Kinetics of incorporation of newly 
synthesized MBP, CNP and PLP into myelin. 
CNS myelin was isolated from rat pups that 
had received intracranial injections of 
35s-methionine (see Materials and Methods) 
and were allowed to survive for the 
designated times. Immunoprecipitates were 
obtained with anti-MBP antibodies (lanes 
a-c), anti-CNPase antibodies (lanes d-f) and 
anti-PLP antibodies (lanes g-i). The rapid 
appearance of MBPs and CNPase is in marked 
contrast to the delayed accumulation of 
labelled PLP, which is first detectable in 
myelin at 30 min post-injection. 
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very close to PLP on SOS-PAGE. Lane 3 shows the results of passing 
the partly purified PLP antiserum through a column which had KBPs 
covalently bound to it. The contaminating KBP antibodies had been 
removed and the resulting affinity purified antiserum recognized 
only PLP. As a guide to the positions of the KBPs rat brain myelin 
was also inununostained with a polyclonal anti-KBP serum (lane 4). 
The kinetics of incorporation of CNPase into myelin were 
determined after intracranial injection of 35s-methionine and 
newly-synthesized CNPase was inunune-precipitated from purified rat 
brain myelin. Newly-synthesized KBPs and PLP were also 
immune-precipitated from purified rat brain myelin. Figure 31 shows 
that newly-synthesized CNPase (lanes d-f) is incorporated into 
myelin with a time course similar to that of the KBPs (lanes a-c). 
This is in marked contrast to the delayed accumulation of PLP, which 
is first detectable in myelin at 30min post-injection. PLP has been 
shown to be synthesized on bound polysomes (Colman et al., 1982) and 
the kinetics of incorporation into myelin are consistent with a 
mechanism whereby the nascent protein is transported from its site 
of synthesis to the growing myelin membrane via the Golgi apparatus. 
3.3 BIOSYNTHESIS OF P2 
i. Inununological Identification of P2 in Rabbit CNS Kyelin 
Purified rabbit brain, spinal cord and sciatic myelin samples 
of equal protein content were electrophoresed and stained with 
Coomassie blue. Figure 32, lanes 1-3 shows an intensely staining 
band in the region corresponding to P2 in both spinal cord and 
sciatic myelin. Western blotting of identical samples using a 
polyclonal/ 
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Fig. 32. Presence of P2 in rabbit spinal cord myelin. 
Rabbit brain, spinal cord and sciatic myelin 
was prepared according to the general method 
(see Materials and Methods) and samples of 
each (30pg protein for Coomassie blue 
staining and 2pg protein for immunoblots) 
were anlysed by SDS-PAGE in 5-15% gradient 
gels (lanes 1-3) or immunostained with 
anti-MBP antibodies (lanes 4-6) and anti-P2 
antibodies (lanes 7-9). 
P2 protein is a component of rabbit CNS myelin, 
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polyclonal antibody raised against bovine P2 demonstrated 
conclusively that P2 is present in large amounts in both rabbit 
spinal cord and sciatic myelin. In contrast, the P2 antiserum 
revealed only a trace amount of P2 in rabbit brain (Figure 32. lanes 
7-9). From the Coomassie blue stained gel the apparent molecular 
weight of P2 was calculated to be 14.k.Da which is in agreement with a 
previously published report (Kitamura et al .• 1980). 
Western blots using an antiserum directed against rat MBPs 
were also performed (Figure 32. lanes 4-6) to determine if the 
antiserum cross-reacted with the rabbit proteins and also as a 
positive control for the blots since it is known that MBPs, while 
components of the PNS myelin of all species studied so far. are 
present in much reduced amounts (Matthieu et al., 1980). 
Only a very slight trace of MBP was observed in lane 6 and 
this is due to the reduction in the amount of antigen electro-
transferred. necessary to avoid overstaining of the brain and spinal 
cord samples (lanes 4 and 5). Positive identification of P2 in 
abundant amounts in rabbit spinal cord myelin relative to the spinal 
cord myelin of bovine and rat (data not shown) led to the decision 
to use this source of P2 for all future experiments involving this 
protein. 
ii. Site of Synthesis of P2 
RNA was extracted from rabbit spinal cord and rabbit spinal 
cord free and bound polysomes and used to programme a wheatgerm 
translation system optimized for rabbit spinal cord total RNA. P2 
was immune-precipitated from translations containing equal amounts 
of TCA-precipitable cpm and the relative amounts of the polypeptide 
in/ 
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in each sample compared. Figure 33 clearly demonstrates that the P2 
protein is synthesized on free polysomes, a situation akin to that 
previously found for MBPs and CNPase. The small amount of P2 
observable in the RER lane (lane 3) is almost certainly due to free 
polysomal contamination in this fraction. 
iii. Non-Enrichment of Myelin-Derived P2 mRNA 
Like the MBPs, P2 is a highly basic protein of relatively low 
molecular weight and it was therefore decided to establish whether 
free polysomes synthesizing P2 were segregated in the myelin sheath 
(as is the case for MBPs) or whether their site of synthesis and 
incorporation into the growing myelin membrane followed more closely 
that of CNPase. Figure 34 demonstrates that when P2 was 
immune-precipitated from translations containing equivalent amounts 
of TCA-precipitable cpm there was no enrichment of P2 mRNA in the 
myelin-associated free polysomes. The ratio of labelled P2 
translated from total spinal cord mRNA to that from 
myelin-associated mRNA was 1:1.1 as calculated from the 
radioactivity associated with each band (3600cpm and 4119cpm 
respectively; lanes 3 and 4). In contrast, a 7-fold enrichment of 
MBP mRNA was observed fr9m RNA isolated from myelin-associated 
polysomes (28300cpm as against 4232cpm in the total spinal cord mRNA 
P2 band; lanes 1 and 2). Thus enrichment of mRNA synthesizing KBPs 
would appear to be a general phenomenon since it has been observed 
in myelin isolated from different parts of the CNS using two 
different species of animals. 
3.4/ 
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Fig. 33. 
Fig. 34. 
Site of synthesis of rabbit spinal cord P2. 
Poly(A)+RNA from rabbit spinal cord (2.7 OD 
U/ml of translation mixture; lane 1) and RNA 
from rabbit spinal cord free polysomes (2.7 
OD U/ml; lane 2) and rough microsomes (5.3 OD 
U/ml; lane 3) were used to programme a 
wheatgerm translation system. After 
translation, the samples were 
5 immune-precipitated (3 x 10 cpm per sample) 
with anti-P2 antibodies, electrophoresed, 
fluorographed and the dried gel exposed to 
X-ray film for 7 days at -70°c. 
The non-enrichment of P2 mRNA associated with 
rabbit spinal cord myelin. 
Rabbit spinal cord poly(A)+RNA (2.7 OD 
U/ml) and rabbit spinal cord 
myelin-associated RNA (2.7 OD U/ml) were 
translated and immune-precipitates were 
prepared (3 x 105cpm per sample) with 
anti-MBP antibodies (lanes 1 and 2) and 
anti-P2 antibodies (lanes 3 and 4) and 
analysed by autoradiography. After a 7 day 
exposure the fluorogram was placed over the 
dried gel to locate the relevant bands, which 
were excised and counted to determine the 
relative ratios of radioactivity in the 
spinal cord total and myelin RNA MBP and P2 
immunoprecipitates. 
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3.4 MEMBRANE ASSOCIATION OF NEWLY-SYNTHESIZED KYELIN PROTEINS 
The interaction of in vitro synthesized MBPs, CNPase and PLP 
with microsomal membranes was examined in wheatgerm translations 
that had been progr8.Jll'Red with rat brain poly(A)+RNA, and to which 
dog pancreatic microsomes and signal recognition particle (SRP) had 
been added at the start of the translations (Figure 35). When KBPs, 
CNPase and PLP were i11111une-precipitated from the supernatant (lanes 
a, c and e) and pellet (lanes b, d and f) fractions it was observed 
that all of the newly synthesized PLP could be recovered with the 
sedimentable microsomes (lanes e and f) as predicted if this major 
intrinsic protein was undergoing cotranslational insertion during 
its synthesis. The reverse was found for the extrinsic protein 
CNPase where all of the newly synthesized product was found in the 
supernatants (lanes c and d) indicating that this protein has a 
specific affinity for the myelin membrane, its natural target 
membrane in vivo. The situation for KBPs was found to be somewhat 
different to that of CNPase however. Even though KBPs, like CNPase, 
are extrinsic membrane proteins synthesized on free polysomes, a 
large proportion (-SO'I.) of the in vitro synthesized KBPs were 
recovered with the microsomes (lanes a and b). These data 
demonstrate striking differences in the behaviour of each of the in 
vitro synthesized polypeptides with the added membranes. The 
binding of the MBPs to microsomes derived from non-brain tissue 
suggests that these highly charged polypeptides will readily and 
non-specifically associate with acidic lipids or phospholipid 
vesicles irrespective of their origin. 
In order to further test this hypothesis MBPs and P2 (like 
MBPs/ 
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Fig. 35. 
Fig. 36. 
The association of newly synthesized KBP, 
CNPase and PLP with membranes in vitro. 
Wheatgerm translations were progr811111led with 
rat brain po1y(A)+RNA (4 OD U/ml) and were 
incubated at the start of the translations 
with dog pancreatic microsomes (DPM) and 
signal recognition particle (SRP). 
Supernatants (lanes a, c and e) and pellets 
(lanes b, d and f) were prepared and 
immunoprecipitated using KBP, CNPase and PLP 
antisera. 
Membrane affinity of newly synthesized MBP 
and P2. 
Wheatgerm translations were programmed with 
rabbit spinal cord poly(A)+RNA (2.7 OD 
U/ml) and were incubated post-translationally 
with either rabbit spinal cord myelin or 
DPM. Hyelin (lanes band g) and DPM (lanes d 
and i) pellets and myelin (lanes c and h) and 
DPM (lanes e and j) supernatants were 
prepared and immunoprecipitated using MBP and 
P2 antisera. Control immunoprecipttates that 
had been incubated in the absence of added 
membranes are also shown (lanes a and f). 
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MBPs a highly charged protein of low molecular weight) were 
immune-precipitated from translations that had been programmed with 
rabbit spinal cord RNA and incubated post-translationally with 
either purified rabbit spinal cord myelin or DPK (Figure 36). The 
non-specific association of MBP with microsomes is seen in lanes d 
and e where a substantial amount of the polypeptides c-20~) are 
found associated with the microsomes. The distribution of KBPs 
observed when myelin was included in the incubation (lanes band c) 
suggests that these proteins have a greater affinity for their 
natural membrane since approximately 501. was found associated with 
the myelin pellet. P2 on the other hand was always recovered in the 
supernatant irrespective of the source of the membranes (lanes g-j) 
and suggests that even though it is a myelin-specific protein its 
association with the myelin membrane is very weak. Lanes a and f 
are immune-precipitated KBPs and P2 from translations that had no 
membranes added and were included as positive controls. 
3.5 CYTOSKELETAL CHARACTERIZATION 
i. The Oligodendrocyte Cytoskeleton 
Single-cell suspensions were prepared fromfreshly dissected 
rat brain and Triton X-100-soluble and -insoluble (cytoskeletal) 
fractions isolated as described in the Materials and Methods 
section. Equal volumes from each fraction were electrophoresed and 
either stained with Coomassie blue or transferred to nitrocellulose 
and hmnunoblotted. Figure 37 shows Coomassie blue staining of the 
fractions where it is apparent that the bulk of the proteins are 
isolated with the detergent-soluble fraction (lane 1). Most of the 
total/ 
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Fig. 37. The protein composition of rat brain 
detergent-soluble and -insoluble fractions. 
Single-cell suspensions were prepared from 
rat brain and the Triton X-100-soluble and 
-insoluble fractions isolated as described in 
Materials and Methods. Equal volumes from 
each fraction were analysed by SDS-PAGE in a 
5-15% gradient gel and lanes 2 and 3 show the 
Coomassie blue stained pattern of proteins in 
the Triton X-100 -soluble and -insoluble 
fractions respectively. Lane 1 consists of 
Coomassie blue stained molecular weight 
markers (~ 2-macroglobulin, 180kDa; 
B-galactosidase, 116kDa; fructose-6-phosphate 
kinase, 84kDa; pyruvate kinase, 58kDa; 
fumarase, 48kDa; lactate dehydrogenase, 
37kDa; triosephosphate isoaaerase, 27kDa). 
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total protein (70~) was recovered in this fraction, the remaining 
30~ being associated with the cytoskeletal fraction. Prolonged 
extraction (up to 5 min) with the CSK buffer did not alter the 
protein distribution (data not shown). This protein distribution is 
in agreement with previous reports (Howe and Hershey, 1984; Fey et 
al., 1986) although a thorough characterization of the individual 
proteins contained within the fractions was not carried out by these 
workers. Of interest in Figure 37 is the enrichment of proteins in 
the tubulin region of the gel contained within the cytoskeletal 
fraction (lane 2). These preliminary results involving Coomassie 
blue staining were encouraging since it is known that microtubules 
are extremely susceptable to depolymerisation during isolation 
(Vallee and Collins, 1986). 
A thorough characterization of the individual protein 
distribution within the soluble and cytoskeletal fractions was 
carried out by Western blotting of equal proportions of each sample 
(Figure 38). Proteins from the three types of cytoskeletal elements 
are represented in lanes c-h comprising tubulin (microtubules), 
actin (microfilaments) and glial fibrillary acidic protein (GFAP), 
an astrocytic intermediate filament marker. That the 
detergent-insoluble residue represents an authentic cytoskeletal 
fraction is shown by the enrichment of tubulin (100~). actin 
(approx. 60~) and GFAP (100~) found within this fraction. CNPase 
(lanes i and j) was found predominantly in the detergent-soluble 
fraction (approx. 9~) as was PLP (100~, lanes k and 1) and all the 
four forms of MBPs (approx. 9~, lanes m and n). There was no 
evidence of a selective enrichment of a particular KBP species 
associated with the cytoskeleton. This was also true for both forms 
of/ 
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Fig. 38. Protein distribution in detergent-soluble and 
-insoluble fractions derived fr011 rat brain. 
Triton X-100-soluble and -insoluble fractions 
were prepared from single-cell suspensions of 
rat brain and equal volumes of each fraction 
electrophoresed in 5-15% gradient gels and 
the proteins electro-transfeered to 
nitrocellulose paper. Iaaun~~lots were 
obtained (lanes c-n) usil2,g a.aonoclonal 
~ 
anti-tubulin antibody (lfioo dilution; 
Serotec), anti-¥-actin (\:2000; Dr C 
Bulinski, UCLA), anti-GFAP (1:2000; Or E 
Bock, University of Copenhagen), affinity 
purified anti-CNPase (1:500), anti-HBP 
(1:1000) and anti-PLP (1:4) polyclonal 
antibodies. Lanes a and b show a blot that 
had been stained with Amido black and 
contains ~olecular weight markers as 
described in the legend to Figure 37. 
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ii. The ftyelin-Associated Cytoskeleton 
Triton X-100-soluble and -insoluble (cytoskeletal) fractions 
were prepared from purified rat brain myelin and subjected to 
protein distribution analysis as for intact cells. Once the optimum 
extraction conditions for the myelin-associated cytoskeleton had 
been established {Figure 39) the pellet was viewed under the EM and 
the protein distribution assessed. The electron micrograph {Figure 
40) shows the presence of filamentous material along with small 
amorphous particles. Thus the detergent-insoluble pellet consists 
of material with a definite macromolecular structure and is not 
simply the result of the sedimentation of protein aggregates. 
Figure 41 (lanes a-d) shows that all of the tubulin and 
approximately 40~ of actin was found in the cytoskeletal fraction. 
Since the tubulin was all in the cytoskeleton it was decided that 
the detergent-insoluble residue was a true reflection of the 
cytoskeleton. The fact that a larger amount of actin was found in 
the detergent-soluble fraction was deemed unimportant since in all 
experiments involving cytoskeletal purifications a substantial 
amount of unpolymerised soluble actin is always observed. 
The distribution of the myelin-specific proteins is 
interesting. Most of the CNPase I was found in the 
detergent-soluble fraction {approx. 70~) however a considerable 
enrichment (approaching 100~) of CNPase II was observed to be 
associated with the cytoskeleton. This appears to be peculiar to 
the myelin-associated cytoskeleton since it is not seen in the 
cytoskeletal extracts from oligodendrocytes {Figure 38). PLP, by 
contrast,/ 
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Fig. 39. Protein composition of rat brain ayelin and 
detergent-soluble and-insoluble fractions. 
Rat brain myelin was extracted with Triton 
X-100 as described in Materials and Methods. 
Rat brain myelin (30µg protein; lane 1) and 
equal volumes of the detergent-soluble and 
-insoluble fractions (lanes 2 and 3 
respectively) were analysed by SOS-PAGE in 
5-15% gradient gels and the proteins stained 
with Coomassie blue. 
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Fig. 40. 
Fig. 41. 
Electron micrograph of the detergent-
insoluble pellet derived from purified rat 
brain myelin. 
Rat brain myelin was extracted with Triton 
X-100 and the detergent-soluble and 
-insoluble fractions isolated. Electron 
micrographs were obtained from ultra-thin 
sections of the detergent-insoluble pellet as 
described in Materials and Methods. 
xl0,000 magnification. 
Scale bar: 1 µm x 10,CX>O 
Protein distribution in the detergent-soluble 
and -insoluble fractions derived from rat 
brain myelin. 
Rat brain myelin was extracted with Triton 
X-100 as described in Materials and Methods 
and equal volumes of the detergent-soluble 
and -insoluble fractions electrophoresed in 
5-15% gradient gels and the proteins 
electro-transferred to nitrocellulose paper. 
Immunoblots were obtained (lanes a-j) using 
anti-tubulin, anti-actin, anti-CNPase, 
anti-PLP and anti-MBP antibodies at the 
dilutions described in Figure 38. 
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contrast, was completely extracted as would be expected of an 
intrinsic membrane protein. The distribution of PLP agrees entirely 
with that found earlier from oligodendrocytes (Figure 38). The 
distribution of KBPs within the soluble and cytoskeletal fractions 
was found to be approximately equal. However, of considerable 
interest was the finding that the pre-large (21.Sk.Da) KBP was found 
almost exclusively with the cytoskeleton. The other KBP species did 
not show this preferential association with the cytoskeleton. 
3.6 CYTOSKELETAL INVOLVEMENT IN MBP AND CNPase SYNTHESIS 
Soluble and cytoskeletal fractions were isolated from 
single-cell suspensions of rat brain as described in Materials and 
Methods (Section 2.6 i). RNA was extracted from these fractions and 
translated in vitro in a wheatgerm translation system. CNPases and 
MBPs were inunune-precipitated from translations containing identical 
numbers of TCA-precipitable cpm and the relative amounts of the 
proteins in translations programmed with detergent-soluble fraction 
RNA and -insoluble (cytoskeletal) fraction RNA were compared. 
Figure 42 clearly shows an increased synthesis of CNPases and KBPs 
from RNA recovered with the cytoskeleton. The enrichment for 
CNPases and MBPs was not quantitated but was estimated to be at 
least 5-fold over that for the same proteins translated using RNA 
from the detergent-soluble fraction. 
The data suggests that the majority of mRNAs coding for these 
proteins are associated with the cytoskeleton during the very a~tive 
period of myelination (ie myelin protein synthesis) from which the 
single-cell suspensions were derived. Unfortunately, due to lack of 
material/ 
14 7 
Fig. 42. The association of MBP and CNPase IIR.NA with 
the detergent-insoluble (cytoskeletal) pellet. 
Single-cell suspensions from rat brain were 
extracted with Triton X-100 as described in 
Materials and Methods and the RNA extracted 
from the detergent-soluble (1.7 OD U/ml) and 
-insoluble (2.7 OD U/ml) fractions used to 
programme a wheatgerm translation system. 
After translation, the samples were 
immune-precipitated (4.5 x 105cpm per 
sample) using anti-MBP (lanes 1 and 2) or 
affinity purified anti-cNPase (lanes 3 and 4) 
antibodies. 
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material attempts to try and determine the distribution of total 
+ poly(A) RNA between the detergent-soluble and cytoskeletal 
fractions proved unsuccessful. 
3.7 LIPID ANALYSIS OF THE ftYELIN-ASSOCIATED CYTOSKELETON 
Preliminary experiments were carried out to determine if there 
were any residual lipid in the myelin-associated cytoskeleton and if 
so, were any particular lipids enriched in this fraction. The 
composition of the individual lipids contained in rat brain myelin 
and the Triton X-100-insoluble pellet were quantitated and the 
results are shown in Table 4. As i" the case of the proteins, the 
associated lipids represent a subset of the total myelin membrane 
lipid. Most of the phosphatidylethanolamine, phosphatidylserine and 
phosphatidylinositol are solubilized by the detergent while 
essentially all of the sphingomyelin remains associated with the 
detergent-insoluble pellet. The phosphatidylcholine and cholesterol 
content of the detergent-insoluble pellet was found to resemble that 
of the myelin membrane. This lipid content and composition between 
the membrane and the matrix is similar to that found in other 
systems (Davies et al., 1984; Apgar et al., 1985). A striking 
feature of the lipid analysis is the considerable enrichment of 
cerebrosides (other than sulphatide which essentially remained the 
same) found associated with the detergent-insoluble pellet. Within 
this cerebroside enrichment an increase in hydroxy cerebroside 
content over that in myelin was observed and conversely, the 
non-hydroxy cerebroside content of the matrix was less than that of 
myelin./ 
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Table 4 Lipid composition of the Triton X-100 insoluble cytoskeleton residue 
compared with that of myelin 
Component 
Total lipid (~mol/mg protein) 
Cholesterol (mol % total lipid) 
Cerebroside (mol % total lipid) 
Non-hydroxy cerebroside (mol % cerebroside) 
Hydroxy cerebroside (mol % cerebroside) 
Sulphatide (mol % total lipid) 
Phospholipid (mol % total lipid) 
Phosphatidylethanolamine (mol % phospholipid) 
Phosphatidylcholine (mol % phospholipid) 
Phosphatidylserine (mol % phospholipid) 
Phosphatidylinositol (mol % phospholipid) 
Sphingomyelin (mol % phospholipid) 
Myelin 
2.46 
39.8 
11.4 
0.13 
1.07 
Triton X-100 
pellet 
0.73 
38.4 
35.6 
32 
68 
0.08 
0.11 
45 
32 
13 
4 
6 
All values are the means of measurements made on at least three different 
preparations. ND: not detected. 
23 
77 
13 
39 
ND 
ND 
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myelin. In order to ensure that the lipid extracted from the 
cytoskeletal fraction was genuinely associated with the cytoskelPtAl 
proteins. purified rat brain myelin and the detergent insoluble 
pellet were subjected to continuous sucrose density gradient 
centrifugation. Measurements or the 00280 of the myelin and 
cytoskeletal fractions revealed two distinct protein peaks (Figure 
43) at 0.64M sucrose and approximately 0.98M sucrose. The protein 
fraction peaking at 0.64M sucrose was taken to be that of myelln and 
ls in agreement with previously published results (Waehneldt, 
1978). The denser protein peak (ranging from approximately 
0.8S-1.l" sucrose) represented the purified myelin-associated 
cytoskeleton. The results from this e1periment also indicated that 
both the myelin and myelin-associated cytoskeleton fractions were 
basically homogeneous since the vast bulk of each sample was 
obtained throughout a relatively narrow sucrose density range. 
The identity or the fractions obtained from these e1perlment1 
was characterized by subjecting equal portions of the fractions to 
SOS-PAGE and Coomassie blue staining. Figure 44 clearly shows that 
the peak corresponding to fraction 10 was authentic rat brain myelln 
since the protein profile observed is very similar to that seen ln 
SOS-PAGE profiles of purified rat brain myelin (see Figure 21). 
That the second denser peak corresponds to the myelin-associated 
cytoskeleton is shown in the lover part of figure 44. A 
considerable enrichment in the cytoskeletal protein tubulin was 
observed. less so with actin. By Coomassie blue staining. fraction 
24 was seen to contain moat protein agreeing well with the 00280 
profile (Figure 43). Also or interest was the presence of residual. 
tightly/ 
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Fig. 43. Sucrose density gradient profile of rat brain 
myelin and the detergent-insoluble fraction 
derived from it. 
Rat brain myelin (2mg protein) and Triton 
X-100-insoluble pellet (from 10ag ayelin 
protein) were layered on top of O.J-l.2M 
sucrose gradients and centrifuged for 16h at 
50,000g. Fractions CO.Sal) were collected 
and SOpl aliquots of each analysed for 
protein content (00280). Rat brain myelln 
(C>--<>); detergent-insoluble pellet(~); 
sucrose concentration (0--0). 
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Fig. 44. Protein profile of fractions obtained from 
sub-fractionation of rat brain ayelin and the 
detergent-insoluble pellet. 
Aliquots (50pl) of the fractions obtained 
from linear sucrose density centrifugation 
(Figure 43) were analysed by SOS-PAGE in 
5-15% gradient gels and the proteins stained 
with Coomassie blue. 
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tightly bound CNPases I and II and KBP. A small amount of PLP was 
also observed within this fraction although the amount was 
insignificant when compared to that contained in the myelin 
fraction. The amounts of CNPases I and II and KBPs found associated 
with the cytoskeleton relative to that in pure myelin were in 
agreement with that found when the detergent-soluble and -insoluble 
fractions from rat brain myelin were analysed by inununoblotting (see 
Figure 41). 
These results were encouraging and further confirmed, since 
continuous sucrose density gradient centrifugation did not alter the 
protein profile of the fraction (compare Figure 39 (lane 3) and 
Figure 44 (fraction 24), for example), the assumption that the 
detergent-insoluble pellet obtained after optimal extraction of rat 
brain myelin was a true representation of the cytoskeleton and that 
these myelin proteins are tightly bound to it. 
Also shown in Figure 44 is the presence of the CNPases 
(Fraction 2). This fraction (termed the floating 'pad') represented 
the top of the sucrose gradient (approx. 0.3M sucrose) and is of 
interest since it has been observed when PNS myelin is 
subfractionated on continuous sucrose gradients (Matthieu et al., 
1979). In the case of the PNS the 'pad' has been shown to consist 
of single-shelled membrane vesicles which contained CNPase activity 
four times higher than that of purified PNS myelin. If this is the 
case for CNS myelin then the 'pad' contains membranes which are 
morphologically and biochemically different from that of myelin 
suggesting that a considerable amount of the CNPases are localized 
in/ 
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in the oligodendrocyte plasma membrane since it has been suggested 
that the floating 'pad' membranes of the PNS are derived from the 
Schwann cell plasma membrane (Matthieu et al., 1979). 
TLC analysis of the sucrose density fractions clearly showed 
that some of the myelin membrane lipids remained associated with the 
detergent-insoluble fraction {Figure 4Sb} discounting the 
possibility that, since the cytoskeleton is isolated by pelleting 
the Triton X-100-insoluble material, lipid was simply cosedimenting 
with the protein and not actually associated with it. Comparison of 
the myelin lipids (Figure 4Sa, fraction 10) with the lipids 
associated with the cytoskeleton (Figure 45b, fraction 24) shows 
that the compositions were different and that a definite enrichment 
of specific lipids with the cytoskeleton existed. The comigration 
of a discrete set of proteins and lipids associated with them in the 
detergent-insoluble fraction suggests that this material may 
represent a submembranous protein matrix that persists following 
removal of most of the myelin membrane protein and lipid rather than 
being simply insoluble protein and/or lipid aggregates. 
Also of interest in Figure 4Sa is the presence of myelin 
lipids in the floating 'pad' (fraction 2). As stated earlier this 
fraction may represent the oligodendrocyte plasma membrane however, 
since the lipid composition of the oligodendrocyte plasma membrane 
is very different from that of myelin, the lipid analysis results of 
this fraction tend to rule out this possibility. The presence of 
myelin lipids has also been observed in the 'pad' when PNS myelin 
was subjected to continuous sucrose density gradient centrifugation 
(Linington et al., 1980). 
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Fig. 45. Lipids associated with rat brain myelin and 
the detergent-insoluble pellet derived from 
it. 
Lipids were extracted from alternate sucrose 
density fractions (400pl), dried and 
subjected to analysis by TLC as described in 
Materials and Methods. Lipids were 
visualized by briefly exposing the TLC plates 
to iodine vapour. a) rat brain myelin 
fractions; b) Triton X-100-insoluble 
fractions. 
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Discussion 
4.1 BIOSYNTHESIS OF THE MAJOR CNS RYELIN PROTEINS AND RECHANISRS 
FOR THEIR ASSOCIATION WITH THE MEMBRANE 
The experiments on the sites of synthesis (in vitro) and 
kinetics of incorporation (in vivo) demonstrate that there are 
vastly different mechanisms whereby extrinsic and intrinsic membrane 
proteins are synthesized and become associated with the growing 
myelin membrane. 
RBPs, CNPases and P2 were all shown to share the same site of 
synthesis on free polysomes which is consistent with their being 
extrinsic membrane proteins, ie. proteins which do not penetrate the 
lipid bilayer to any great extent. The results obtained from the 
labelling studies in vivo reinforce this view. The rapid 
incorporation of MBPs and CNPases into developing myelin suggests 
that these proteins are discharged from free polysomes into the cell 
sap and are then incorporated post-translationally into myelin. 
In contrast to MBPs and CNPase the major intrinsic membrane 
protein of myelin, PLP. was observed to incorporate into developing 
myelin only after a significant lag period. The presence of 
covalently attached fatty acid to PLP (Stoffyn and Folch-Pi, 1971) 
strongly suggests that the protein traverses the Golgi complex since 
this is the site at which viral envelope glycoproteins appear to be 
modified (Schmidt and Schlesinger, 1979). If this is the case with 
PLP then the protein probably reaches the oligodendrocyte plasma 
membrane via Golgi-derived vesicles. Once the vesicles fuse with 
the plasma membrane, transport of PLP to the myelinating process 
would require lateral diffusion. Alternatively, the Golgi-derived 
vesicles could transfer PLP to the myelinating process where it 
could/ 
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could participate in myelin formation directly. 
The membrane-binding experiments in which membranes were added 
either during synthesis or post-translationally to in vitro 
translations demonstrate striking differences in the behaviour of 
each of the in vitro synthesized polypeptides. When DPM and SRP 
were added during translation, PLP underwent normal co-translational 
insertion into the membranes. This result was expected since Colman 
et al. (1982) have shown that PLP is synthesized on bound 
polysomes. or interest is the fact that the primary translation 
product was of the same electrophoretic mobility as the mature 
polypeptide indicating that the signal sequence is not cleaved 
during membrane insertion. It would thus appear that the uncleaved 
amino terminal signal sequence may be one of a series of insertion 
and halt signals, situated along the polypeptide chain. which enable 
the complex membrane disposition of PLP to be attained. 
On the other hand, the binding of MBPs to the microsomes 
demonstrates that these highly charged proteins will readily and 
non-specifically (since the microsomes were derived from non-neural 
sources) associate with acidic lipids or phospholipid vesicles. 
That this non-specific association almost certainly does not occur 
in vivo has been shown by the observation that rough microsomes 
labelled!!!. vivo were never found to contain labelled MBPs (Colman, 
o. R., personal connunication). The finding that the CNPases did 
not associate with the microsomes suggests that the oligodendrocyte 
possesses very different mechanisms for targetting the CNPases and 
NBPs to the myelin membrane since it would have to prevent MBPs from 
associating with other intracellular membranes. The results 
involving/ 
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involving the post-translational addition of DPM and myelin to newly 
synthesized MBP and P2 tend to re-inforce this view. MBP was 
observed to have an equal affinity for both types of membranes, 
therefore even in the presence of its target membrane (myelin) the 
degree of specific association that ftBP exhibits with myelin is no 
more than that of non-specific sticking to, most probably, any type 
of membrane that exists in the cell. P2, on the other hand, 
displayed a similar pattern to that of the CNPases with added 
microsomes although the fact that this protein did not associate 
with myelin may mean that the association of P2 with the myelin 
membrane is very weak. Since the function of P2 may be that of a 
lipid carrier (see Section 1.3 ii e) it may require the presence of 
lipid in order for it to maintain a strong interaction with myelin. 
Possibly the most interesting result obtained from the in 
vitro translation experiments was the finding that an RNA fraction 
isolated from purified myelin was enriched in messages encoding KBPs 
but was not enriched in messages that coded for the CNPases and P2. 
This is surprising since the three proteins are similar in that they 
are all of the extrinsic type and synthesized on free polysomes and 
all are highly charged with pis of 9 or greater. Therefore these 
results suggest that there exist mechanisms for the transport of 
newly synthesized MBPs to the myelin membrane that differ 
considerably from that of the CNPases and P2. This discovery has 
important implications for the cell biology of myelination since it 
suggests that free polysomes synthesize the MBPs close to the myelin 
membrane which may serve to ensure that nascent MBP polypeptides 
associate/ 
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associate rapidly (in vivo labelling results) and specifically 
(membrane-binding results) with the correct membrane. 
A number of mechanisms could be involved in the establishment 
and maintenance of a segregation of those free polysomes 
synthesizing MBPs to the oligodendrocyte periphery (ie. the 
myelinating process). The cellular cytoskeleton would appear to be 
an attractive candidate for a specific association with MBP mRNAs in 
the myelinating process. Once this segregation is established the 
nascent KBPs could interact directly with other protein or lipid 
constituents of the growing sheath. 
4.2 CYTOSKELETAL INVOLVEMENT IN MYELINOGENESIS 
Many nucleated cells have been shown to have present within 
them extensive cytoskeletal systems that include microtubules, 
microfilaments and intermediate filaments (Timasheff and Grisham, 
1980; Lazarides, 1980). Non-ionic detergent extraction of cells and 
isolated membranes from several mammalian sources has demonstrated 
the occurrence of detergent-insoluble components associated with the 
plasma membrane. Partial characterization of the components of 
these detergent-insoluble fractions has led to suggestions that they 
represent submembranous cytoskeletal complexes associated with the 
membrane. Studies of the detergent-insoluble plasma membrane 
fraction of murine tumour and lymphoid cells have led to the 
proposal that this material represents a membrane skeletal structure 
distinct from the filamentous cytoskeletal systems previously 
characterized (Apgar et al., 1985). The results presented here on 
the characterization of both the oligodendrocyte (whole cell) and 
myelin-associated (isolated membrane) cytoskeletons show that there 
is/ 
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is a discrete association of some of the major CNS myelin proteins 
with this detergent-insoluble matrix. The fact that the unique 
polypeptide distribution of the detergent-soluble and -insoluble 
fractions was found to remain unaltered in both the oligodendrocyte 
and myelin-associated cytoskeletons even after prolonged extraction 
with Triton X-100 means that the complex represents a 
limit-solubility product. On comparing the PLP distribution from 
both types of cytoskeleton it was observed that none of this protein 
was found associated with the detergent-insoluble matrix. This 
suggests that PLP either has no direct association with cytoskeletal 
elements or that if an interaction exists it is through 
extrinsic-type 'linker' proteins as is the case with the erythrocyte 
cytoskeleton (Gratzer. 1981). 
In contrast to PLP. significant differences in the 
distribution of MBPs and CNPases were observed within both the 
oligodendrocyte and myelin-associated detergent-soluble and 
-insoluble fractions. In the case of the MBPs the fact that the 
vast majority of all the four polypeptide species are seen to be 
extracted by the detergent in oligodendrocytes suggests that these 
may be newly synthesized MBPs which are en route from their site of 
synthesis to the myelin membrane proper. Such cytoskeletal 
association that exists might be transient reflecting cytoskeletal 
transport of these proteins rather than a stable cytoskeletal 
association that may be involved in some dynamic event such as the 
maintenance of myelin membrane stability. Evidence that 
post-translational cytoskeletal transport of MBPs may exist was 
shown by the fact that the majority of mRNAs coding for MBPs are 
attached/ 
166 
attached to the cytoskeleton during synthesis and it is not 
unreasonable to assume that once synthesis has been completed the 
nascent polypeptides (still attached to the cytoskeleton) are then 
targetted to the myelin membrane using this transport system. 
The KBP distribution within the myelin-associated cytoskeleton 
is more puzzling. Why should there be a significant enrichment of 
the pre-large MBP within the cytoskeletal fraction? This question 
is difficult to answer but may reflect the role that this MBP 
species has to play in the stabilization of the shape and/or 
structure of individual myelin bilayer leaflets rather than in 
interactions between the many membrane layers themselves. The 
distribution of the three smaller MBP polypeptides between the 
deteregent-soluble and -insoluble fractions was found to be about 
equal and may reflect the different role that these MBPs have as 
opposed to the pre-large MBP. It could be envisaged that 
maintenance of the multilamellar structure is due to the association 
of these three MBP species with one another (via dimerization for 
example) and forming the well known major dense line. 
The CNPase distribution within the detergent-soluble and 
-insoluble fractions of both oligodendrocytes and myelin. when 
examined closely. appears to resemble that of the MBPs in that most 
of the proteins (both CNPase I and II) were solubilized by the 
detergent in oligodendrocytes but a selective enrichment of one of 
the CNPases (CNPase II) was seen to be associated with the 
myelin-associated cytoskeleton. Again. as with the MBPs. the 
'soluble' oligodendrocyte-derived CNPases may be newly synthesized 
protein which is in the process of being cytoskeletally transported 
from/ 
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from the cell body to the periphery of the cell since most of the 
CNPase mRNAs are attached to the cytoskeleton during synthesis. The 
fact that it is CNPase II which is enriched in the cytoskeleton may 
be due to phosphorylation since this appears to be the only 
post-translational difference between CNPase I and II which has been 
detected so far. 
It has been shown recently that the phosphorylation of tubulin 
enhances its interaction with membranes and that this effect is 
reversible (Hargreaves et al .• 1986). A strong and stable 
association between the cytoskeleton and the myelin membrane. 
mediated by CNPase II (and perhaps pre-large MBP). could therefore 
be envisaged with a flexibility of movement between the structures 
allowed for by the reversible phosphorylation and dephosphorylation 
of these proteins. 
The lipid analysis results have shown that there is a 
considerable enrichment of sphingomyelin and cerebrosides (other 
than sulphatides) associated with the detergent-insoluble matrix of 
purified myelin. If this reflects an association that occurs in the 
native membrane then the matrix may have significant influence on 
the properties of the lipid bilayer. There is some evidence for a 
role of the spectrin matrix of erythrocytes in maintaining the lipid 
asymmetry in these membranes (Williamson et al .• 1982) and the 
myelin cytoskeletal matrix may have a similar role. The binding of 
lipids directly to cytoskeletal elements would therefore be seen to 
shift the equilibrium distribution of sphingomyelin. cerebrosides 
and phosphatidylethanolamine. Cerebrosides. although not specific 
to the myelin membrane, are much enriched in this structure and have 
been/ 
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been thought of as the most 'myelin-like lipid'. The observation 
that so much of this particular class of lipid is found associated 
with the detergent-insoluble fraction isolated from purified myelin 
suggests that this lipid may have a dynamic rather than a purely 
structural role to play in myelin membrane formation and/or 
stabilization. 
It must be stressed that work on establishing a role for the 
cytoskeleton in myelinogenesis is at an early stage and although 
these results are consistent with the idea that the myelin membrane 
contains a detergent-insoluble matrix (or cytoskeleton) that may 
play a role in myelin formation and/or stabilization via a direct 
interaction between cytoskeletal and myelin-specific proteins and 
the membrane itself much more research will be needed to determine 
how these proteins interact with each other and to elucidate the 
true function of the myelin-associated cytoskeleton. 
The experiments outlined here reveal that there must be a 
remarkable diversity of mechanisms that the oligodendrocyte must 
employ to organize the developing myelin membrane and, once formed, 
to stabilize what is, after all, an extremely complex structure. 
The fact that the oligodendrocyte is so extended in space, and that 
it must in the course of myelination rapidly generate large amounts 
of membrane, probably has resulted in a higher degree of development 
of the general subcellular mechanisms for targetting of protein and 
lipid and their interaction with subcellular components than exist 
in other cells. 
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Future Work 
5 SUGGESTIONS FOR FUTURE WORK 
It is crucial for our understanding of myelination and 
remyelination that we understand the factors that promote the 
activation of the genes responsible for the synthesis and assembly 
of the ayelin aeabrane. Rodern molecular biological techniques 
provide powerful tools for the study of such events. This 
methodology allows one to detect the subtle modifications in 
cellular behaviour and organization that control the expression of 
genes and therefore it is envisaged that the continued study of 
myelinogenesis will. in the future. utilize these techniques to the 
full. 
The technique of in situ hybridization. using either cloned 
cDNAs of the major CNS myelin proteins or synthetic oligonucleotides 
could be used to probe the appearance and localization of specific 
mRNAs encoding these proteins. Allied to this would be the use of 
Northern blot analysis of RNA isolated from both the developing 
brain and cultured oligodendrocytes to study the relationship 
between the ti11ely expression of genes encoding the major CNS myelin 
proteins and the process of myelination itself. If the initial 
cause of multiple sclerosis was found to be due to a virus {and 
therein lies a major goal for future work itself) then techniques 
like in situ hybridization could be used to test the effect of the 
virus on oligodendrocyte gene expression. A novel way in which 
molecular biological techniques could be put to use is in 
detenaining the (presUJ1ed) internal signal sequences(s) of PLP. 
This could be done by a coupled cell-free transcription/translation 
assay using fragments of the cloned PLP DNA and looking for the 
segment(s)/ 
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segment(s) of the polypeptide chain which cotranslationally insert 
into microsomes. 
From a biochemical point of view it would be interesting to 
purify and sequence rat brain CNPase II and also to map the 
phosphorylation site(s) contained within it. Since it appears that 
the only proteins contained in the floating 'pad' from sucrose 
density gradient centrifugation of myelin are CNPase I and II then 
this fraction could be used in the purification process. Until 
sequencing of CNPase II is carried out then the true nature of the 
relationship between CNPase I and II will remain unknown. Are 
CNPase I and II the products of separate mRNAs or is the difference 
between them due to some major post-translational modification other 
than phosphorylation? 
There are many areas to explore with regard to the involvement 
of the cytoskeleton in myelinogenesis. It would be interesting to 
establish whether any of the major CNS myelin proteins bind to 
purified elements of the cytoskeleton, for example pre-large MBP and 
CNPase II with purified tubulin and actin. If binding was detected 
then the addition of antibodies to those proteins and their effect 
on myelinating oligodendrocytes in culture could be examined. Once 
the myelin process has been extended from the oligodendrocyte it 
must be able to recognize a nerve axon in order for spiralling of 
the process to colll'llence. A major aim of research in the future 
would be to identify these recognition proteins since it may turn 
out that these cell-surface proteins might be responsible for the 
tight envelopment of the nerve axon. 
The involvement of the cellular cytoskeleton in myelin 
membrane/ 
172 
membrane protein biosynthesis could be studied using the 
microfilament-disrupting drug cytochalasin. Cell-free translation 
of RNA isolated from the cytoskeletal fractions of cytochalasin 
treated cultured oligodendrocytes or single-cell suspensions from 
brain would determine if the mRNA was truly bound to microfilaments 
during synthesis since the mRNA would then be found predominantly in 
the detergent-soluble fraction. 
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